{"doc_id": "si-2021-0261-reg-1", "parent_doc_id": "si-2021-0261", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": null, "text_raw": "1.", "text_norm": "1", "start_char": 1032, "end_char": 1036, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-2021", "parent_doc_id": "si-2021-0261", "section_id": "reg-2021", "section_label": "Regulation 2021.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "Commencement", "text_raw": "2021. \n\nCommencement", "text_norm": "2021 commencement", "start_char": 1036, "end_char": 1059, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-2", "parent_doc_id": "si-2021-0261", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "2. These Regulations come into operation on 26 May 2021.", "text_raw": "2. These Regulations come into operation on 26 May 2021. \n\nInterpretation", "text_norm": "2 regulation come operation 26 may 2021 interpretation", "start_char": 1059, "end_char": 1135, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-3", "parent_doc_id": "si-2021-0261", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "3. (1) In these Regulations—", "text_raw": "3. (1) In these Regulations— \n\n“approved examiner” means— \n\n(a) \n\n(b) \n\n(c) \n\n(d) \n\na Chief Medical Scientist located at an official laboratory, \n\na Consultant Microbiologist located at an official laboratory, \n\na Deputy Public Analyst located at a Public Analyst’s Laboratory, \n\nan Executive Analytical Chemist located at a Public Analyst’s \nLaboratory, \n\n(e) \n\na Public Analyst located at a Public Analyst’s Laboratory, or \n\n1 OJ No. L 117, 5.5.2017, p. 1. \n2 OJ No. L 130, 24.4.2020, p. 18. \n3 OJ No. L 218, 13.8.2008, p. 30. \n4 OJ No. L 169, 25.6.2019, p. 1. \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 28th May, 2021. \n\n \n \n \n \n \n \n \n \n \n \n\f[261] 3 \n\n(f) \n\na person, or member of a class of persons, designated for that \npurpose by the Authority; \n\n“authorised officer” means— \n\n(a) \n\n(b) \n\na person appointed under Regulation 28, or \n\nan officer of Customs and Excise; \n\n“Authority” means the Health Products Regulatory Authority; \n\n“combination product” means a medical device excluded from the general \napplication of the EU Regulation pursuant to Article 1(8) (second subparagraph), \n(9) or (10) thereof; \n\n“compliance notice” mean a notice under Regulation 32; \n\n“device” means— \n\n(a) \n\n(b) \n\n(c) \n\na medical device, \n\nan accessory for a medical device, or \n\na product listed in Annex XVI to the EU Regulation to which the \nEU Regulation applies pursuant to Article 1(2) thereof, \n\nand does not include— \n\n(i) \n\na product or other substance excluded by Article 1(6) of the \nEU Regulation, \n\n(ii) a combination product, or \n\n(iii) an in-house device; \n\n“EU Regulation” means Regulation (EU) 2017/745 of the European Parliament \nand of the Council of 5 April 20171, as amended by Regulation (EU) 2020/561 \nof the European Parliament and of the Council of 23 April 20202; \n\n“information society service” has the meaning assigned to it by point (b) of \nArticle 1(1) of Directive (EU) 2015/1535 of the European Parliament and of the \nCouncil of 9 September 20155; \n\n “in-house device” means a medical device which— \n\n(a) \n\n(b) \n\nis manufactured and used only within a health institution, \n\ncomplies with all of the conditions in Article 5(5) of the EU \nRegulation, and \n\nis not manufactured on an industrial scale; \n\n“inspect” includes search; \n\n“Market Surveillance Regulation” means Regulation (EU) 2019/1020 of the \nEuropean Parliament and of the Council of 20 June 20194; \n\n“member state” means— \n\n(a) \n\na member state of the European Economic Area, or \n\n(b) Switzerland; \n\n5 OJ No. L 241, 17.9.2015, p. 1. \n\n \n \n\f4 [261] \n\n“Minister” means the Minister for Health; \n\n“National REC” means a National Research Ethics Committee for Clinical \nInvestigations of Medical Devices \n\n“official laboratory” means— \n\n(a) \n\n(b) \n\n(c) \n\n(d) \n\n(e) \n\nthe Public Analyst’s Laboratory, Cork, \n\nthe Public Analyst’s Laboratory, Dublin, \n\nthe Public Analyst’s Laboratory, Galway, \n\na laboratory designated by the Authority for the purposes of the \nEU Regulation, or \n\na laboratory designated for the purposes of the EU Regulation in \nanother member state; \n\n“online interface” means any software, including a website, part of a website or \nan application, that is operated by or on behalf of an economic operator, and \nwhich serves to give end users access to the economic operator's products; \n\n“person responsible for regulatory compliance” means any natural person who \nmeets the requirements set out in Article 15(1) of the EU Regulation; \n\n“premises” means any place (physical or virtual), ship or other vessel, aircraft, \nrailway wagon or other vehicle or other mobile facility, and includes a container \nused to transport a medical device or other relevant thing; \n\n“prohibition order” means an order under Regulation 33; \n\n“quarantine notice” means a notice under Regulation 31; \n\n“record” includes, in addition to a record in writing— \n\n(a) \n\n(b) \n\na disc, tape, sound-track or other device in which information, \nsounds or signals are embodied so as to be capable, with or \nwithout the aid or some other instrument, of being reproduced in \nlegible or audible form, \n\na film, tape or other device in which visual images are embodied \nso as to be capable, with or without the aid or some other \ninstrument, of being reproduced in visual form, \n\n(c) \n\na photograph, and \n\n(d) \n\na digital record, \n\nand any reference to a copy of a record includes— \n\n(i) \n\n(ii) \n\nin the case of a record to which subparagraph (a) of this \ndefinition applies, a transcript of the sounds or signals \nembodied therein, \n\nin the case of a record to which subparagraph (b) of this \ndefinition applies, a still reproduction of the images \nembodied therein, and \n\n(iii) \n\nin the case of a record to which subparagraphs (a) and (b) \nof this definition apply, such a transcript together with such \na still reproduction; \n\n \n\f[261] 5 \n\n“Regulations of 1994” means the European Communities (Medical Devices) \nRegulations 1994 (S.I. No. 252 of 1994); \n\n“relevant thing” means— \n\n(a) \n\n(b) \n\n(c) \n\n(d) \n\na device, \n\na combination product, \n\nan in-house device, \n\nany article or substance used in the manufacture, processing, \npackaging, \nlabelling, preparation, storage, distribution or \nadvertising of a device or product referred to in subparagraph (a), \n(b) or (c); or \n\n(e) \n\nanother product being used, or purporting to be used, for medical \npurpose; \n\n“supply by mail order” means any supply made, after solicitation of custom by \nthe supplier, or by another person in the chain of supply whether inside or outside \nof the State, without the supplier and the customer being simultaneously present \nand using a means of communication at a distance, whether written or electronic, \nto convey the custom solicitation and the order for supply. \n\n(2) A word or expression which is used in these Regulations and which is \nalso used in the EU Regulation has, unless the context otherwise requires, the \nsame meaning in these Regulations as it has in the EU Regulation. \n\nAdditional functions of Authority", "text_norm": "3 (1) regulations-- approved examiner means-- (a) (b) (c) (d) chief medical scientist located official laboratory consultant microbiologist located official laboratory deputy public analyst located public analyst laboratory executive analytical chemist located public analyst laboratory (e) public analyst located public analyst laboratory 1 oj no l 117 5.5.2017 p 1 2 oj no l 130 24.4.2020 p 18 3 oj no l 218 13.8.2008 p 30 4 oj no l 169 25.6.2019 p 1 notice making statutory instrument published iris oifigiuil 28th may 2021 261 3 (f) person member class person designated purpose authority authorised officer means-- (a) (b) person appointed regulation 28 officer custom excise authority mean health product regulatory authority combination product mean medical device excluded general application eu regulation pursuant article 1(8) (second subparagraph) (9) (10) thereof compliance notice mean notice regulation 32 device means-- (a) (b) (c) medical device accessory medical device product listed annex xvi eu regulation eu regulation applies pursuant article 1(2) thereof include-- (i) product substance excluded article 1(6) eu regulation (ii) combination product (iii) in-house device eu regulation mean regulation (eu) 2017 745 european parliament council 5 april 20171 amended regulation (eu) 2020 561 european parliament council 23 april 20202 information society service meaning assigned point (b) article 1(1) directive (eu) 2015 1535 european parliament council 9 september 20155 in-house device mean medical device which-- (a) (b) manufactured used within health institution complies condition article 5(5) eu regulation manufactured industrial scale inspect includes search market surveillance regulation mean regulation (eu) 2019 1020 european parliament council 20 june 20194 member state means-- (a) member state european economic area (b) switzerland 5 oj no l 241 17.9.2015 p 1 4 261 minister mean minister health national rec mean national research ethic committee clinical investigation medical device official laboratory means-- (a) (b) (c) (d) (e) public analyst laboratory cork public analyst laboratory dublin public analyst laboratory galway laboratory designated authority purpose eu regulation laboratory designated purpose eu regulation another member state online interface mean software including website part website application operated behalf economic operator serf give end user access economic operator product person responsible regulatory compliance mean natural person meet requirement set article 15(1) eu regulation premise mean place (physical virtual) ship vessel aircraft railway wagon vehicle mobile facility includes container used transport medical device relevant thing prohibition order mean order regulation 33 quarantine notice mean notice regulation 31 record includes addition record writing-- (a) (b) disc tape sound-track device information sound signal embodied capable without aid instrument reproduced legible audible form film tape device visual image embodied capable without aid instrument reproduced visual form (c) photograph (d) digital record reference copy record includes-- (i) (ii) case record subparagraph (a) definition applies transcript sound signal embodied therein case record subparagraph (b) definition applies still reproduction image embodied therein (iii) case record subparagraphs (a) (b) definition apply transcript together still reproduction 261 5 regulation 1994 mean european community (medical devices) regulation 1994 (s.i no 252 1994) relevant thing means-- (a) (b) (c) (d) device combination product in-house device article substance used manufacture processing packaging labelling preparation storage distribution advertising device product referred subparagraph (a) (b) (c) (e) another product used purporting used medical purpose supply mail order mean supply made solicitation custom supplier another person chain supply whether inside outside state without supplier customer simultaneously present using mean communication distance whether written electronic convey custom solicitation order supply (2) word expression used regulation also used eu regulation unless context otherwise requires meaning regulation eu regulation additional function authority", "start_char": 1135, "end_char": 7155, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-4", "parent_doc_id": "si-2021-0261", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "4. (1) In addition to the functions conferred on the Authority by Regulation", "text_raw": "4. (1) In addition to the functions conferred on the Authority by Regulation \n3 of the European Union (Medical Devices and In Vitro Diagnostic Medical \nDevices) Regulations 2017 (S.I. No. 547 of 2017), the functions of the State \nreferred to in Articles 4, 5(5), 6(4), 15(1)(a), 15(6)(a), 21(3), 40(1), 42, 44(12), \n47(2), 47(4), 51(3), 59(3), 62(4)(a), 62(6), 70, 71(2), (3) and (4), 72(5), 73, 74, \n75, 76, 77, 78, 80, 89(2), 90, 95, 96, 98, 100, 102(2), 106(11), 109(3), 109(4), \nand 110 of the EU Regulation shall be performed by the Authority. \n\n(2) The Authority is designated as the market surveillance authority for \nmedical devices for the purposes of Regulation (EC) No. 765/2008 of the \nEuropean Parliament and of the Council of 9 July 20083 and the Market \nSurveillance Regulation. \n\nCo-operation and exchange of information", "text_norm": "4 (1) addition function conferred authority regulation 3 european union (medical device vitro diagnostic medical devices) regulation 2017 (s.i no 547 2017) function state referred article 4 5(5) 6(4) 15(1)(a) 15(6)(a) 21(3) 40(1) 42 44(12) 47(2) 47(4) 51(3) 59(3) 62(4)(a) 62(6) 70 71(2) (3) (4) 72(5) 73 74 75 76 77 78 80 89(2) 90 95 96 98 100 102(2) 106(11) 109(3) 109(4) 110 eu regulation shall performed authority (2) authority designated market surveillance authority medical device purpose regulation (ec) no 765 2008 european parliament council 9 july 20083 market surveillance regulation co-operation exchange information", "start_char": 7155, "end_char": 7994, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-5", "parent_doc_id": "si-2021-0261", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "5. (1) With the objective of performing its functions under these Regulations", "text_raw": "5. (1) With the objective of performing its functions under these Regulations \nand the EU Regulation, the Authority may cooperate, as appropriate, with \nDepartments of State, agencies and bodies having, by law, responsibility for any \nmatter relating to any aspect of those functions. \n\n(2) For the purpose of performing its functions under these Regulations and \nthe EU Regulation, the Authority may exchange information, including personal \ndata, to the extent that it is necessary and appropriate, with relevant public \n\n \n \n \n\f6 [261] \n\nauthorities only for the purpose of performing their functions, including the \nfollowing bodies: \n\n(a) \n\n(b) \n\n(c) \n\n(d) \n\n(e) \n\n(f) \n\n(g) \n\n(h) \n\n(i) \n\n(j) \n\n(k) \n\n(l) \n\nthe Garda Síochána; \n\nthe Revenue Commissioners; \n\nSport Ireland; \n\nthe Health Service Executive; \n\nthe Pharmaceutical Society of Ireland; \n\nthe Medical Council; \n\nthe Dental Council; \n\nthe Nursing and Midwifery Board; \n\nthe Department of Health; \n\nthe Department of Employment Affairs and Social Protection; \n\nthe Environmental Protection Agency (EPA); \n\nthe Competition and Consumer Protection Commission (CCPC); \n\n(m) \n\nthe Department of, Enterprise, Trade and Employment. \n\n(n) \n\n(o) \n\n(p) \n\n(q) \n\nthe Health Information and Quality Authority (HIQA); \n\nlocal authorities; \n\ncompetent authorities outside the State; and \n\nEuropean Union bodies. \n\nPART 2 \n\nIMPLANTABLE DEVICES AND SINGLE-USE DEVICES \n\nImplant card and supply of information re. implanted device", "text_norm": "5 (1) objective performing function regulation eu regulation authority may cooperate appropriate department state agency body law responsibility matter relating aspect function (2) purpose performing function regulation eu regulation authority may exchange information including personal data extent necessary appropriate relevant public 6 261 authority purpose performing function including following body (a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) garda siochana revenue commissioner sport ireland health service executive pharmaceutical society ireland medical council dental council nursing midwifery board department health department employment affair social protection environmental protection agency (epa) competition consumer protection commission (ccpc) (m) department enterprise trade employment (n) (o) (p) (q) health information quality authority (hiqa) local authority competent authority outside state european union body part 2 implantable device single-use device implant card supply information re implanted device", "start_char": 7994, "end_char": 9472, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-6", "parent_doc_id": "si-2021-0261", "section_id": "reg-6", "section_label": "Regulation 6.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "6. A health institution shall make available to a patient who has been", "text_raw": "6. A health institution shall make available to a patient who has been \n\nimplanted with an implantable device by the health institution— \n\n(a) \n\nthe information referred to in Article 18(1) of the EU Regulation, \nby electronic, written or other appropriate means, and \n\n(b) \n\nthe implant card, which shall bear the patient’s identity, \n\nas soon as possible, but no later than 30 working days after the implantation of \nthe device. \n\nReprocessing and further use of single-use devices", "text_norm": "6 health institution shall make available patient implanted implantable device health institution-- (a) information referred article 18(1) eu regulation electronic written appropriate mean (b) implant card shall bear patient identity soon possible later 30 working day implantation device reprocessing use single-use device", "start_char": 9472, "end_char": 9958, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-7", "parent_doc_id": "si-2021-0261", "section_id": "reg-7", "section_label": "Regulation 7.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "7. (1) A person shall not reprocess a single-use device to make it suitable for", "text_raw": "7. (1) A person shall not reprocess a single-use device to make it suitable for \nfurther use in a member state unless there is compliance with Article 17(6), (7) \nand (8) of the EU Regulation. \n\n \n \n \n \n \n\f[261] 7 \n\n(2) A person who reprocesses a single-use device pursuant to paragraph (1) \n\nshall— \n\n(a) \n\nassume the obligations incumbent on manufacturers laid down in \nthe EU Regulation, including obligations relating to the \ntraceability of the reprocessed device in accordance with Chapter \nIII of the EU Regulation, and \n\n(b) be considered to be a producer for the purpose of Article 3(1) of \n\nCouncil Directive 85/374/EEC of 25 July 19856. \n\nPART 3 \n\nCLINICAL INVESTIGATIONS \n\nPersons entitled to provide medical care to subjects", "text_norm": "7 (1) person shall reprocess single-use device make suitable use member state unless compliance article 17(6) (7) (8) eu regulation 261 7 (2) person reprocesses single-use device pursuant paragraph (1) shall-- (a) assume obligation incumbent manufacturer laid eu regulation including obligation relating traceability reprocessed device accordance chapter iii eu regulation (b) considered producer purpose article 3(1) council directive 85 374 eec 25 july 19856 part 3 clinical investigation person entitled provide medical care subject", "start_char": 9958, "end_char": 10698, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-8", "parent_doc_id": "si-2021-0261", "section_id": "reg-8", "section_label": "Regulation 8.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "8. For the purposes of Article 62(4)(j) of the EU Regulation, the following", "text_raw": "8. For the purposes of Article 62(4)(j) of the EU Regulation, the following \npersons are entitled to provide medical care to subjects of clinical investigations, \nas appropriate: \n\n(a) \n\n(b) \n\n(c) \n\n(d) \n\n(e) \n\n(f) \n\na registered medical practitioner; \n\na registered dentist; \n\na registered nurse or midwife, \n\na person registered in the Register of Pharmacists established \nunder section 13(1) of the Pharmacy Act 2007 (No. 20 of 2007); \n\na person registered in the Register of Optometrists established and \nmaintained by the Optical Registration Board under section 36 of \nthe Health and Social Care Professionals Act 2005 (No. 27 of \n2005); \n\na person registered in another register maintained under the \nHealth and Social Care Professionals Act 2005 for the purpose of \nproviding services for or in connection with the prevention, \ndiagnosis or treatment of human illness. \n\nQualifications of investigators", "text_norm": "8 purpose article 62(4)(j) eu regulation following person entitled provide medical care subject clinical investigation appropriate (a) (b) (c) (d) (e) (f) registered medical practitioner registered dentist registered nurse midwife person registered register pharmacist established section 13(1) pharmacy act 2007 (no 20 2007) person registered register optometrist established maintained optical registration board section 36 health social care professional act 2005 (no 27 2005) person registered another register maintained health social care professional act 2005 purpose providing service connection prevention diagnosis treatment human illness qualification investigator", "start_char": 10698, "end_char": 11611, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-9", "parent_doc_id": "si-2021-0261", "section_id": "reg-9", "section_label": "Regulation 9.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "9. For the purposes of Article 62(6) of the EU Regulation, the investigator", "text_raw": "9. For the purposes of Article 62(6) of the EU Regulation, the investigator \nshall be a person of appropriate education, training and experience to assume \nresponsibility for the proper conduct of the clinical investigation, as determined \nby the sponsor, and such determination shall be subject to review by the \nAuthority as part of its assessment of the clinical investigation application. \n\n6 OJ No. L 210, 7.8.1985, p. 29. \n\n \n \n \n \n \n \n \n \n\f8 [261] \n\nQualifications of persons carrying out prior interviews", "text_norm": "9 purpose article 62(6) eu regulation investigator shall person appropriate education training experience assume responsibility proper conduct clinical investigation determined sponsor determination shall subject review authority part assessment clinical investigation application 6 oj no l 210 7.8.1985 p 29 8 261 qualification person carrying prior interview", "start_char": 11611, "end_char": 12126, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-10", "parent_doc_id": "si-2021-0261", "section_id": "reg-10", "section_label": "Regulation 10.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "10. For the purposes of Article 63(2)(c) of the EU Regulation, the following", "text_raw": "10. For the purposes of Article 63(2)(c) of the EU Regulation, the following \npersons are deemed to be appropriately qualified to carry out prior interviews \nwith subjects, or, where the subject is not able to give informed consent, his or \nher legal representative for the purpose of obtaining his or her informed consent, \nas appropriate to the purpose of the clinical investigation: \n\n(a) \n\n(b) \n\n(c) \n\na registered medical practitioner; \n\na registered dentist; \n\na person referred to in Regulation 8(c), (d), (e) or (f), whose \ntraining, experience and qualifications have been assessed by the \nprincipal investigator and determined to be appropriate to qualify \nhim or her to conduct the interview. \n\nSubmission of opinion of national research ethics committee opinion", "text_norm": "10 purpose article 63(2)(c) eu regulation following person deemed appropriately qualified carry prior interview subject subject able give informed consent legal representative purpose obtaining informed consent appropriate purpose clinical investigation (a) (b) (c) registered medical practitioner registered dentist person referred regulation 8(c) (d) (e) (f) whose training experience qualification assessed principal investigator determined appropriate qualify conduct interview submission opinion national research ethic committee opinion", "start_char": 12126, "end_char": 12902, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-11", "parent_doc_id": "si-2021-0261", "section_id": "reg-11", "section_label": "Regulation 11.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "11. A sponsor of a clinical investigation being conducted in the State shall", "text_raw": "11. A sponsor of a clinical investigation being conducted in the State shall \nsubmit to the Authority a copy of the opinion or opinions of a National REC in \nrespect of the clinical investigation— \n\n(a) where it is available at the time of the application for an \n\nauthorisation or notification, at that time, or \n\n(b) \n\nas soon as a copy is available thereafter. \n\nCo-ordination between Authority and National REC", "text_norm": "11 sponsor clinical investigation conducted state shall submit authority copy opinion opinion national rec respect clinical investigation-- (a) available time application authorisation notification time (b) soon copy available thereafter co-ordination authority national rec", "start_char": 12902, "end_char": 13319, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-12", "parent_doc_id": "si-2021-0261", "section_id": "reg-12", "section_label": "Regulation 12.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "12. The Authority and a National REC may cooperate on the execution of", "text_raw": "12. The Authority and a National REC may cooperate on the execution of \ntasks pursuant to the EU Regulation, to the extent that it is necessary and \nappropriate, for the purpose of performing their functions. \n\nStarting of clinical investigations", "text_norm": "12 authority national rec may cooperate execution task pursuant eu regulation extent necessary appropriate purpose performing function starting clinical investigation", "start_char": 13319, "end_char": 13568, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-13", "parent_doc_id": "si-2021-0261", "section_id": "reg-13", "section_label": "Regulation 13.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "13. A sponsor shall not start a clinical investigation, whether in relation to a", "text_raw": "13. A sponsor shall not start a clinical investigation, whether in relation to a \ndevice referred to in Article 70(7)(a) or (b) of the EU Regulation until the \nAuthority has notified the sponsor of its authorisation in accordance with the \ntime period referred to in Article 70(7)(b) of the EU Regulation. \n\nRequirements in respect of clinical investigations not performed for purpose \nlisted in Article 62(1) or Article 74 of EU Regulation", "text_norm": "13 sponsor shall start clinical investigation whether relation device referred article 70(7)(a) (b) eu regulation authority notified sponsor authorisation accordance time period referred article 70(7)(b) eu regulation requirement respect clinical investigation performed purpose listed article 62(1) article 74 eu regulation", "start_char": 13568, "end_char": 14011, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-14", "parent_doc_id": "si-2021-0261", "section_id": "reg-14", "section_label": "Regulation 14.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "14. (1) This Regulation applies to clinical investigations not performed", "text_raw": "14. (1) This Regulation applies to clinical investigations not performed \npursuant to any of the purposes listed in Article 62(1) or Article 74 of the EU \nRegulation. \n\n(2) In addition to the requirements referred to in Article 82(1) of the EU \nRegulation, the following requirements shall also apply to clinical investigations \nreferred to in paragraph (1): \n\n(a) \n\nthe requirements in Articles 69 and 76 of the EU Regulation; \n\n \n \n \n \n \n\f[261] 9 \n\n(b) \n\n(c) \n\nthe sponsor shall notify the Authority in writing at least 30 days \nprior to its commencement; \n\nthe sponsor shall record and report adverse events during the \nclinical investigation in line with the requirements of Article 80 \nof the EU Regulation, unless the device is CE marked, in which \ncase the provisions of Articles 87 to 90, and the acts adopted \npursuant to Article 91 of the EU Regulation, shall apply instead, \nand \n\n(d) \n\nsuch additional requirements as the Authority may, on a case by \ncase basis, require the sponsor to comply with following the \nreceipt of notification from the sponsor under subparagraph (b). \n\nAppeals of decisions in relation to clinical investigations", "text_norm": "14 (1) regulation applies clinical investigation performed pursuant purpose listed article 62(1) article 74 eu regulation (2) addition requirement referred article 82(1) eu regulation following requirement shall also apply clinical investigation referred paragraph (1) (a) requirement article 69 76 eu regulation 261 9 (b) (c) sponsor shall notify authority writing least 30 day prior commencement sponsor shall record report adverse event clinical investigation line requirement article 80 eu regulation unless device ce marked case provision article 87 90 act adopted pursuant article 91 eu regulation shall apply instead (d) additional requirement authority may case case basis require sponsor comply following receipt notification sponsor subparagraph (b) appeal decision relation clinical investigation", "start_char": 14011, "end_char": 15165, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-15", "parent_doc_id": "si-2021-0261", "section_id": "reg-15", "section_label": "Regulation 15.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "15. (1) A sponsor may, within 28 days of receipt of the relevant decision", "text_raw": "15. (1) A sponsor may, within 28 days of receipt of the relevant decision \n\nfrom the Authority, bring an appeal against— \n\n(a) \n\n(b) \n\n(c) \n\na decision by the Authority, pursuant to Article 70(3) of the EU \nRegulation, to refuse authorisation for a clinical investigation on \nthe grounds that it does not fall within the scope of the EU \nRegulation or that the application dossier is not complete, \n\na decision by the Authority, pursuant to Article 71(4) of the EU \nRegulation, to refuse authorisation for a clinical investigation on \none of the grounds listed in that provision, or \n\na decision by the Authority, pursuant to Article 75(3)(a) of the \nEU Regulation, \nto refuse authorisation for a substantial \nmodification to a clinical investigation. \n\n(2) The Authority shall publish guidelines setting out the procedures \n\napplicable to appeals under paragraph (1). \n\nPART 4 \n\nOFFENCES AND PENALTIES \n\nOffences by manufacturers", "text_norm": "15 (1) sponsor may within 28 day receipt relevant decision authority bring appeal against-- (a) (b) (c) decision authority pursuant article 70(3) eu regulation refuse authorisation clinical investigation ground fall within scope eu regulation application dossier complete decision authority pursuant article 71(4) eu regulation refuse authorisation clinical investigation one ground listed provision decision authority pursuant article 75(3)(a) eu regulation refuse authorisation substantial modification clinical investigation (2) authority shall publish guideline setting procedure applicable appeal paragraph (1) part 4 offence penalty offence manufacturer", "start_char": 15165, "end_char": 16098, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-16", "parent_doc_id": "si-2021-0261", "section_id": "reg-16", "section_label": "Regulation 16.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "16. (1) Subject to Regulation 40, a manufacturer who—", "text_raw": "16. (1) Subject to Regulation 40, a manufacturer who— \n\n(a) makes available on the market or puts into service a device which \nfails to comply with applicable common specifications pursuant \nto Article 9 of the EU Regulation, \n\n(b) makes available on the market or puts into service a device which \nhas not been designed or manufactured in accordance with the \nrequirements of the EU Regulation, \n\n \n \n \n \n \n\f10 [261] \n\n(c) \n\nfails to establish, document, implement or maintain a system for \nrisk management of devices as described in Section 3 of Annex I \nto the EU Regulation, \n\n(d) makes available on the market or puts into service a device \nwithout conducting a clinical evaluation in accordance with the \nrequirements set out in Article 61 of, and Annex XIV to, the EU \nRegulation, including a PMCF, \n\n(e) makes available on the market or puts into service a device other \nthan a custom-made device but fails to draw up or keep up to date \ntechnical documentation in accordance with Article 10(4) of the \nEU Regulation, \n\n(f) makes available on the market or puts into service a custom-made \ndevice but fails to draw up, keep up to date or keep available for \nthe Authority documentation in accordance with Section 2 of \nAnnex XIII to the EU Regulation, \n\n(g) \n\nfails to keep technical documentation, a declaration of conformity \nor a copy of any relevant certificate, including any amendments \nand supplements, issued in accordance with Article 56 of the EU \nRegulation, available for the Authority in accordance with Article \n10(8) of the EU Regulation, \n\n(h) \n\nfails to establish or maintain a quality management system in \naccordance with Article 10(9) of the EU Regulation, \n\n(i) makes available on the market or puts into service a device which \nis not accompanied by the information set out in Section 23 of \nAnnex I to the EU Regulation in the manner required by Article \n10(11) of the EU Regulation, \n\n(j) \n\n(k) \n\n(l) \n\nplaces on the market or puts into service a device which it \nconsiders or has reason to believe is not in conformity with the \nEU Regulation and fails to take corrective action in accordance \nwith Article 10(12) of the EU Regulation, and inform the \ndistributor, and where applicable the authorised representative \nand importers, accordingly, \n\nfails to comply with a request under Article 10(14) of the EU \nRegulation, to provide information and documentation necessary \nto demonstrate the conformity of a device, or a sample free of \ncharge or grant access to a device, \n\nfails to comply with a request under Article 10(14) of the EU \nRegulation to cooperate with corrective action taken to eliminate \nor, if that is not possible, mitigate the risks posed by a device \nwhich it has placed on the market or put into service, \n\n(m) \n\nfails to put in place a necessary measure in accordance with \nArticle 10(16) of the EU Regulation to provide sufficient \n\n \n\f[261] 11 \n\nfinancial coverage in respect of potential liability under Council \nDirective 85/374/EEC of 25 July 19857, \n\n(n) \n\nfails to have available within his or her organisation, or \npermanently and continuously at his or her disposal, as required \nby Article 15 of the EU Regulation, at least one person \nresponsible for regulatory compliance, \n\n(o) has more than one person responsible for regulatory compliance \nand fails to stipulate in writing their respective areas of \nresponsibility, \n\n(p) places a medical device on the market in respect of which a person \nresponsible for regulatory compliance has not been appointed in \naccordance with Article 15 of the EU Regulation, \n\n(q) \n\nis not established in a member state and places on the market a \ndevice in respect of which an authorised representative has not \nbeen designated in accordance with Article 11 of the EU \nRegulation, \n\n(r) \n\nchanges its authorised representative without entering into an \nagreement in accordance with Article 12 of the EU Regulation, \n\n(s) makes available on the market or puts into service a device which \ncontains a substance which is classified as a CMR substance \nlisted in Annex I point 10.4 to the EU Regulation, other than in \naccordance with the corresponding restrictions laid down in that \nAnnex, \n\n(t) makes available on the market or puts into service a device, other \nthan a custom made or investigational device, that does not have \naffixed to it a CE marking in accordance with Article 20 of the \nEU Regulation, \n\n(u) \n\nfails to provide with an implantable device the required \ninformation, in accordance with Article 18 of the EU Regulation, \nso that it can be provided to the patient implanted with the device, \n\n(v) makes available on the market or puts into service a device, other \nthan a custom made or investigational device, but fails to draw up \na declaration of conformity in relation thereto in accordance with \nArticle 19 of the EU Regulation, \n\n(w) places on the market a device, other than a custom-made device, \nwithout first assigning to it a UDI in accordance with Article \n27(3) of the EU Regulation and transferring to the UDI database \nthe information referred to in that provision, \n\n(x) \n\nplaces a device on the market without placing UDI carriers on the \nlabel of the device and on all higher levels of packaging, in \naccordance with Article 27(4) of the EU Regulation, \n\n(y) \n\nfails to keep up-to-date a list of all UDIs that he or she has \nassigned, \n\n7 OJ No. L 210, 7.8.1985, p. 29. \n\n \n \n\f12 [261] \n\n(z) \n\nplaces on the market a device, other than a custom-made device, \nwhich has not been registered in the electronic system in \naccordance with Article 29 of the EU Regulation, \n\n(aa) places on the market a device, other than a custom-made device, \nwithout first assigning a basic UDI-DI to it in accordance with \nArticle 29 of the EU Regulation, \n\n(bb) places on the market a device, other than a custom-made device, \nwithout providing the basic UDI-DI to the UDI database together \nwith the other core elements referred to in Part B of Annex VI \nrelated to that device, \n\n(cc) places on the market a device, other than a custom-made device, \nwithout first entering or verifying in Eudamed the information \nreferred to in Article 29(4) of the EU Regulation, \n\n(dd) fails to update information entered in Eudamed pursuant to \n\nArticle 29(4) of the EU Regulation, \n\n(ee) \n\nin the case of an implantable device and class III device, other \nthan a custom-made or investigational device, which it places on \nthe market, fails to include on the label or instructions for use \ninformation as to where the summary of safety and clinical \nperformance referred to in Article 32 of the EU Regulation is \navailable, \n\n(ff) places on the market a custom-made device without first \nfollowing the procedure set out in Annex XIII to the EU \nRegulation and drawing up the statement set out in Section 1 of \nthat Annex, \n\n(gg) fails to keep up to date and keep available for the Authority \ndocumentation in accordance with Section 2 of Annex XIII. \n\n(hh) fails to fulfil the post-market surveillance obligations in \n\naccordance with Chapter VII, Section 1 of the EU Regulation, \n\n(ii) \n\n(jj) \n\nfails to comply with vigilance requirements in accordance with \nChapter VII, Section 2 of the EU Regulation, \n\nterminates its contract with a notified body and enters into a \ncontract with a new notified body without executing an agreement \nin compliance with Article 58(1) of the EU Regulation, or \n\n(kk) fails to update the clinical evaluation of a device it has placed on \nthe market or put into service, or the documentation relating \nthereto, in accordance with Article 61(11) of the EU Regulation, \n\n(ll) \n\nfails to comply with the registration obligations laid out in Article \n31 of the EU Regulation, \n\nis guilty of an offence. \n\n(2) The offences listed in paragraph (1) also apply to an authorised \nrepresentative where it has been validly delegated, or is otherwise legally \nresponsible for, the applicable manufacturer’s obligation under the EU \nRegulation, in accordance with Article 11 thereof. \n\n \n\f[261] 13 \n\n(3) Subject to paragraphs (4) and (5), the offences listed in paragraph (1) also \napply to a distributor, importer or other natural or legal person where he, she or \nit— \n\n(a) makes available on the market a device under his, her or its name, \nregistered trade name or registered trade mark, except in cases \nwhere a distributor or importer enters into an agreement with a \nmanufacturer whereby the manufacturer is identified as such on \nthe label and is responsible for meeting the requirements placed \non manufacturers in the EU Regulation, \n\n(b) \n\nchanges the intended purpose of a device already placed on the \nmarket or put into service, or \n\n(c) modifies a device already placed on the market or put into service \nin such a way that compliance with the applicable requirements \nof the EU Regulation may be affected, \n\nin which circumstances, such person shall be regarded as the manufacturer for \nthe purpose of the said offences. \n\n(4) Paragraph (3)(a) shall not apply to any person who, while not considered \na manufacturer, assembles or adapts for an individual patient a device already \non the market without changing its intended purpose. \n\n(5) For the purposes of paragraph (3)(c), the actions listed in Article 16(2) \nof the EU Regulation shall not be considered to be a modification of a device \nthat could affect its compliance with the applicable requirements. \n\n(6) The offences listed in paragraph (1) also apply to a person who combines \na device with a system or procedure pack in the circumstances referred to in \nArticle 22(4) of the EU Regulation, and in such circumstances such person shall \nbe regarded as the manufacturer and the system or procedure pack shall be \nregarded as a device in its own right. \n\n(7) The offences listed in paragraph (1) also apply to a person who \nreprocesses a single-use device to make it suitable for further use within a \nmember state, pursuant to Regulation 7, in which case the person shall be \nconsidered to be the manufacturer of the reprocessed device. \n\nOffences by authorised representatives", "text_norm": "16 (1) subject regulation 40 manufacturer who-- (a) make available market put service device fails comply applicable common specification pursuant article 9 eu regulation (b) make available market put service device designed manufactured accordance requirement eu regulation 10 261 (c) fails establish document implement maintain system risk management device described section 3 annex eu regulation (d) make available market put service device without conducting clinical evaluation accordance requirement set article 61 annex xiv eu regulation including pmcf (e) make available market put service device custom-made device fails draw keep date technical documentation accordance article 10(4) eu regulation (f) make available market put service custom-made device fails draw keep date keep available authority documentation accordance section 2 annex xiii eu regulation (g) fails keep technical documentation declaration conformity copy relevant certificate including amendment supplement issued accordance article 56 eu regulation available authority accordance article 10(8) eu regulation (h) fails establish maintain quality management system accordance article 10(9) eu regulation (i) make available market put service device accompanied information set section 23 annex eu regulation manner required article 10(11) eu regulation (j) (k) (l) place market put service device considers reason believe conformity eu regulation fails take corrective action accordance article 10(12) eu regulation inform distributor applicable authorised representative importer accordingly fails comply request article 10(14) eu regulation provide information documentation necessary demonstrate conformity device sample free charge grant access device fails comply request article 10(14) eu regulation cooperate corrective action taken eliminate possible mitigate risk posed device placed market put service (m) fails put place necessary measure accordance article 10(16) eu regulation provide sufficient 261 11 financial coverage respect potential liability council directive 85 374 eec 25 july 19857 (n) fails available within organisation permanently continuously disposal required article 15 eu regulation least one person responsible regulatory compliance (o) one person responsible regulatory compliance fails stipulate writing respective area responsibility (p) place medical device market respect person responsible regulatory compliance appointed accordance article 15 eu regulation (q) established member state place market device respect authorised representative designated accordance article 11 eu regulation (r) change authorised representative without entering agreement accordance article 12 eu regulation (s) make available market put service device contains substance classified cmr substance listed annex point 10.4 eu regulation accordance corresponding restriction laid annex (t) make available market put service device custom made investigational device affixed ce marking accordance article 20 eu regulation (u) fails provide implantable device required information accordance article 18 eu regulation provided patient implanted device (v) make available market put service device custom made investigational device fails draw declaration conformity relation thereto accordance article 19 eu regulation (w) place market device custom-made device without first assigning udi accordance article 27(3) eu regulation transferring udi database information referred provision (x) place device market without placing udi carrier label device higher level packaging accordance article 27(4) eu regulation (y) fails keep up-to-date list udis assigned 7 oj no l 210 7.8.1985 p 29 12 261 (z) place market device custom-made device registered electronic system accordance article 29 eu regulation (aa) place market device custom-made device without first assigning basic udi-di accordance article 29 eu regulation (bb) place market device custom-made device without providing basic udi-di udi database together core element referred part b annex vi related device (cc) place market device custom-made device without first entering verifying eudamed information referred article 29(4) eu regulation (dd) fails update information entered eudamed pursuant article 29(4) eu regulation (ee) case implantable device class iii device custom-made investigational device place market fails include label instruction use information summary safety clinical performance referred article 32 eu regulation available (ff) place market custom-made device without first following procedure set annex xiii eu regulation drawing statement set section 1 annex (gg) fails keep date keep available authority documentation accordance section 2 annex xiii (hh) fails fulfil post-market surveillance obligation accordance chapter vii section 1 eu regulation (ii) (jj) fails comply vigilance requirement accordance chapter vii section 2 eu regulation terminates contract notified body enters contract new notified body without executing agreement compliance article 58(1) eu regulation (kk) fails update clinical evaluation device placed market put service documentation relating thereto accordance article 61(11) eu regulation (ll) fails comply registration obligation laid article 31 eu regulation guilty offence (2) offence listed paragraph (1) also apply authorised representative validly delegated otherwise legally responsible applicable manufacturer obligation eu regulation accordance article 11 thereof 261 13 (3) subject paragraph (4) (5) offence listed paragraph (1) also apply distributor importer natural legal person it-- (a) make available market device name registered trade name registered trade mark except case distributor importer enters agreement manufacturer whereby manufacturer identified label responsible meeting requirement placed manufacturer eu regulation (b) change intended purpose device already placed market put service (c) modifies device already placed market put service way compliance applicable requirement eu regulation may affected circumstance person shall regarded manufacturer purpose said offence (4) paragraph (3)(a) shall apply person considered manufacturer assembles adapts individual patient device already market without changing intended purpose (5) purpose paragraph (3)(c) action listed article 16(2) eu regulation shall considered modification device could affect compliance applicable requirement (6) offence listed paragraph (1) also apply person combine device system procedure pack circumstance referred article 22(4) eu regulation circumstance person shall regarded manufacturer system procedure pack shall regarded device right (7) offence listed paragraph (1) also apply person reprocesses single-use device make suitable use within member state pursuant regulation 7 case person shall considered manufacturer reprocessed device offence authorised representative", "start_char": 16098, "end_char": 26186, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-17", "parent_doc_id": "si-2021-0261", "section_id": "reg-17", "section_label": "Regulation 17.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "17. Subject to Regulation 40, an authorised representative who—", "text_raw": "17. Subject to Regulation 40, an authorised representative who— \n\n(a) \n\n(b) \n\n(c) \n\nfails to provide to the Authority a copy of a mandate agreed \nbetween it and the manufacturer which is in accordance with \nArticle 11 of the EU Regulation, \n\nfails to verify that the EU declaration of conformity and technical \ndocumentation have been drawn up in respect of a device in \nrespect of which he or she has been designated, \n\nif applicable, fails to verify that an appropriate conformity \nassessment has been carried out by the manufacturer of a device \nin respect of which he or she has been designated, \n\n \n \n\f14 [261] \n\n(d) \n\nfails to keep available, at the disposal of the Authority for the \nperiod referred to in Article 10(8) of the EU Regulation, a copy \nof— \n\n(i) \n\nthe technical documentation, \n\n(ii) \n\nthe EU declaration of conformity, or \n\n(iii) any relevant certificate issued in accordance with Article 56 \n\nof the EU Regulation, \n\nin relation to a device in respect of which he or she has been \ndesignated, \n\nfails to comply with the registration obligations laid down in \nArticle 31 of the EU Regulation in relation to a device in respect \nof which he or she has been designated, \n\nfails to verify that the manufacturer of a device in respect of which \nhe or she has been designated has complied with the registration \nobligations laid down in Articles 27 and 29 of the EU Regulation, \n\nfails to provide to the Authority, on request, information or \ndocumentation necessary to demonstrate the conformity of a \ndevice in respect of which he or she has been designated, \n\nfails to forward to the manufacturer of a device in respect of \nwhich he or she has been designated any request from the \nAuthority for samples or access to the device, or fails to verify \nthat the Authority receives such samples or is given such access, \n\nfails to cooperate with the Authority on any preventive or \ncorrective action taken to eliminate or mitigate the risks posed by \na device in respect of which he or she has been designated, \n\nfails to immediately inform the manufacturer of a device in \nrespect of which he or she has been designated about a complaint \nor report from a healthcare professional, patient or user about a \nsuspected incident related to the device, \n\nfails to immediately inform the Authority or any relevant notified \nbody of the termination of its mandate, where required under \nArticle 11(6) of the EU Regulation, or \n\nfails to have permanently and continuously at his or her disposal \nat least one person responsible for regulatory compliance, in \naccordance with Article 15(6) of the EU Regulation, \n\n(e) \n\n(f) \n\n(g) \n\n(h) \n\n(i) \n\n(j) \n\n(k) \n\n(l) \n\nis guilty of an offence. \n\nOffences by distributors", "text_norm": "17 subject regulation 40 authorised representative who-- (a) (b) (c) fails provide authority copy mandate agreed manufacturer accordance article 11 eu regulation fails verify eu declaration conformity technical documentation drawn respect device respect designated applicable fails verify appropriate conformity assessment carried manufacturer device respect designated 14 261 (d) fails keep available disposal authority period referred article 10(8) eu regulation copy of-- (i) technical documentation (ii) eu declaration conformity (iii) relevant certificate issued accordance article 56 eu regulation relation device respect designated fails comply registration obligation laid article 31 eu regulation relation device respect designated fails verify manufacturer device respect designated complied registration obligation laid article 27 29 eu regulation fails provide authority request information documentation necessary demonstrate conformity device respect designated fails forward manufacturer device respect designated request authority sample access device fails verify authority receives sample given access fails cooperate authority preventive corrective action taken eliminate mitigate risk posed device respect designated fails immediately inform manufacturer device respect designated complaint report healthcare professional patient user suspected incident related device fails immediately inform authority relevant notified body termination mandate required article 11(6) eu regulation fails permanently continuously disposal least one person responsible regulatory compliance accordance article 15(6) eu regulation (e) (f) (g) (h) (i) (j) (k) (l) guilty offence offence distributor", "start_char": 26186, "end_char": 28909, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-18", "parent_doc_id": "si-2021-0261", "section_id": "reg-18", "section_label": "Regulation 18.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "18. Subject to Regulation 40, a distributor who—", "text_raw": "18. Subject to Regulation 40, a distributor who— \n\n \n \n \n \n\f[261] 15 \n\n(a) makes available on the market a device, other than a custom-made \nor investigational device, which has not been CE marked in \naccordance with Article 20 of the EU Regulation, \n\n(b) makes available on the market a device which does not have an \nEU declaration of conformity in accordance with Article 19 of the \nEU Regulation, \n\n(c) makes available on the market a device which is not accompanied \nby the information to be supplied by the manufacturer in \naccordance with Article 10(11) of the EU Regulation, \n\n(d) makes available on the market an imported device in respect of \nwhich the importer has not complied with the requirements in \nArticle 13(3) of the EU Regulation, \n\n(e) makes available on the market a device, other than a custom-made \ndevice, which has not been assigned a Unique Device Identifier \n(UDI) by the manufacturer, \n\n(f) makes available on the market a device which it considers, or has \n\nreason to believe, is not in conformity with the EU Regulation, \n\n(g) \n\n(h) \n\n(i) \n\n(j) \n\n(k) \n\n(l) \n\nconsiders or has reasons to believe that a device which the \ndistributor has made available on the market is not in conformity \nwith the EU Regulation and fails to inform the manufacturer and \nthe importer, and where applicable the manufacturer’s authorised \nrepresentative, of such non-conformity in accordance with Article \n14(2) of the EU Regulation, \n\nconsiders or has reason to believe that a device presents a serious \nrisk or is a falsified device and fails to inform the relevant \ncompetent authority of such risk in accordance with Regulation \n14(2) of the EU Regulation, \n\nstores or transports a device without complying with the \nconditions set by the manufacturer, \n\nconsiders or has reason to believe that a device which he or she \nhas made available on the market is not in conformity with the \nEU Regulation and fails to take corrective measures in \naccordance with Article 14(4) of the EU Regulation, \n\nreceives a complaint or report about a suspected incident related \nto a device it has made available, but fails to comply with \nRegulation 14(5) of the EU Regulation, \n\nfails to provide the Authority with information, documentation, \ncooperation or a sample, or access to, a device following a request \nby the Authority under Article 14(6) of the EU Regulation, or \n\n(m) carries out any of the activities referred to in Article 16(2) of the \n\nEU Regulation and fails to— \n\n(i) \n\nprovide the information required by Article 16(3) of the EU \nRegulation with the device concerned, \n\n \n\f16 [261] \n\n(ii) have in place a quality management system in accordance \nwith the requirements of Article 16(3) of the EU \nRegulation, or \n\n(iii) provide the manufacturer and the competent authority with \ninformation or documentation in accordance with Article \n16(4) of the EU Regulation, \n\nis guilty of an offence. \n\nOffences by importers", "text_norm": "18 subject regulation 40 distributor who-- 261 15 (a) make available market device custom-made investigational device ce marked accordance article 20 eu regulation (b) make available market device eu declaration conformity accordance article 19 eu regulation (c) make available market device accompanied information supplied manufacturer accordance article 10(11) eu regulation (d) make available market imported device respect importer complied requirement article 13(3) eu regulation (e) make available market device custom-made device assigned unique device identifier (udi) manufacturer (f) make available market device considers reason believe conformity eu regulation (g) (h) (i) (j) (k) (l) considers reason believe device distributor made available market conformity eu regulation fails inform manufacturer importer applicable manufacturer authorised representative non-conformity accordance article 14(2) eu regulation considers reason believe device present serious risk falsified device fails inform relevant competent authority risk accordance regulation 14(2) eu regulation store transport device without complying condition set manufacturer considers reason believe device made available market conformity eu regulation fails take corrective measure accordance article 14(4) eu regulation receives complaint report suspected incident related device made available fails comply regulation 14(5) eu regulation fails provide authority information documentation cooperation sample access device following request authority article 14(6) eu regulation (m) carry activity referred article 16(2) eu regulation fails to-- (i) provide information required article 16(3) eu regulation device concerned 16 261 (ii) place quality management system accordance requirement article 16(3) eu regulation (iii) provide manufacturer competent authority information documentation accordance article 16(4) eu regulation guilty offence offence importer", "start_char": 28909, "end_char": 31844, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-19", "parent_doc_id": "si-2021-0261", "section_id": "reg-19", "section_label": "Regulation 19.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "19. Subject to Regulation 40, an importer who—", "text_raw": "19. Subject to Regulation 40, an importer who— \n\n(a) places on the market a device which has not been CE marked in \n\naccordance with Article 20 of the EU Regulation, \n\n(b) places on the market a device which does not have an EU \ndeclaration of conformity in accordance with Article 19 of, and \nAnnex IV to, the EU Regulation, \n\n(c) \n\nplaces on the market a device which the importer considers, or \nhas reason to believe, is not in conformity with the requirements \nof the EU Regulations, \n\n(d) places on the market a device in respect of which the \n\nmanufacturer has not been identified, \n\n(e) \n\n(f) \n\nplaces on the market a device in respect of which an authorised \nrepresentative has not been designated in accordance with Article \n11 of the EU Regulation, \n\nis established in the State and fails to inform the Authority that it \nconsiders, or has reason to believe, that a device it intended to \nplace on the market presents a serious risk or is a falsified device, \n\n(g) places on the market a device which is not labelled in accordance \nwith the EU Regulation or is not accompanied by the required \ninstructions for use, \n\n(h) places on the market a device, other than a custom-made device, \nwhich has not been assigned a UDI by the manufacturer in \naccordance with Article 27 of the EU Regulation, \n\n(i) \n\n(j) \n\nplaces on the market a device without complying with the \ninformation and labelling requirements in Article 13(3) of the EU \nRegulation, \n\nplaces on the market a device, other than a custom-made device, \nwhich has not been registered in the electronic system in \naccordance with Article 29 of the EU Regulation, \n\n(k) within 2 weeks of placing on the market a device, other than a \ncustom-made device, which has already been registered on the \nelectronic system referred to in Article 30 of the EU Regulation, \non the market, fails to— \n\n \n \n\f[261] 17 \n\n(i) \n\nverify that the manufacturer or authorised representative of \nthe device has provided the information referred to in \nSection 1 of Part A of Annex VI to the EU Regulation to, \nor \n\n(ii) add its details to the relevant entry or entries in, \n\nthe said electronic system. \n\nstores or transports a device under its responsibility in a manner \ncontrary to the requirements of Article 13(5) of the EU \nRegulation, \n\nfails to keep a register, or provide information, in accordance with \nArticle 13(6) of the EU Regulation, \n\nfails to inform the manufacturer or authorised representative, in \naccordance with Article 13(7) of the EU Regulation, where it \nconsiders or has reasons to believe that a device which the \nimporter has placed on the market is not in conformity with the \nEU Regulation, \n\nfails to cooperate in corrective measures required under Article \n13(7) of the EU Regulation, \n\nfails to inform the relevant competent authorities or notified body, \nin accordance with Article 13(7) of the EU Regulation, where a \ndevice it has placed on the market presents a serious risk, \n\nto \n\nto forward \n\nthe manufacturer or \n\nfails \nits authorised \nrepresentative information in relation to complaints or reports of \nsuspected incidents related to a device the importer has placed on \nthe market, in accordance with Regulation 13(8) of the EU \nRegulation, \n\nfails to keep a copy of the EU declaration of conformity or any \nrelevant certificate, in accordance with Article 13(9) of the EU \nRegulation, \n\nfails to provide the Authority with cooperation, or samples or \naccess to a device, upon request by the Authority under Article \n13(10) of the EU Regulation, or \n\n(l) \n\n(m) \n\n(n) \n\n(o) \n\n(p) \n\n(q) \n\n(r) \n\n(s) \n\n(t) \n\ncarries out any of the activities referred to in Article 16(2) of the \nEU Regulation and fails to— \n\n(i) \n\nprovide the information required by Article 16(3) of the EU \nRegulation with the device concerned, \n\n(ii) have in place a quality management system in accordance \nwith the requirements of Article 16(3) of the EU \nRegulation, or \n\n(iii) provide a manufacturer or the Authority with information \nor documentation in accordance with Article 16(4) of the \nEU Regulation, \n\nis guilty of an offence. \n\n \n\f18 [261] \n\nOffences – economic operators", "text_norm": "19 subject regulation 40 importer who-- (a) place market device ce marked accordance article 20 eu regulation (b) place market device eu declaration conformity accordance article 19 annex iv eu regulation (c) place market device importer considers reason believe conformity requirement eu regulation (d) place market device respect manufacturer identified (e) (f) place market device respect authorised representative designated accordance article 11 eu regulation established state fails inform authority considers reason believe device intended place market present serious risk falsified device (g) place market device labelled accordance eu regulation accompanied required instruction use (h) place market device custom-made device assigned udi manufacturer accordance article 27 eu regulation (i) (j) place market device without complying information labelling requirement article 13(3) eu regulation place market device custom-made device registered electronic system accordance article 29 eu regulation (k) within 2 week placing market device custom-made device already registered electronic system referred article 30 eu regulation market fails to-- 261 17 (i) verify manufacturer authorised representative device provided information referred section 1 part annex vi eu regulation (ii) add detail relevant entry entry said electronic system store transport device responsibility manner contrary requirement article 13(5) eu regulation fails keep register provide information accordance article 13(6) eu regulation fails inform manufacturer authorised representative accordance article 13(7) eu regulation considers reason believe device importer placed market conformity eu regulation fails cooperate corrective measure required article 13(7) eu regulation fails inform relevant competent authority notified body accordance article 13(7) eu regulation device placed market present serious risk forward manufacturer fails authorised representative information relation complaint report suspected incident related device importer placed market accordance regulation 13(8) eu regulation fails keep copy eu declaration conformity relevant certificate accordance article 13(9) eu regulation fails provide authority cooperation sample access device upon request authority article 13(10) eu regulation (l) (m) (n) (o) (p) (q) (r) (s) (t) carry activity referred article 16(2) eu regulation fails to-- (i) provide information required article 16(3) eu regulation device concerned (ii) place quality management system accordance requirement article 16(3) eu regulation (iii) provide manufacturer authority information documentation accordance article 16(4) eu regulation guilty offence 18 261 offence - economic operator", "start_char": 31844, "end_char": 35987, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-20", "parent_doc_id": "si-2021-0261", "section_id": "reg-20", "section_label": "Regulation 20.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "20. Subject to Regulation 40, an economic operator who—", "text_raw": "20. Subject to Regulation 40, an economic operator who— \n\n(a) \n\n(b) \n\n(c) \n\n(d) \n\n(e) \n\n(f) \n\n(g) \n\n(h) \n\n(i) \n\n(j) \n\nfails to identify any of the persons or institutions referred to in \nArticle 25(2) of the EU Regulation during the period referred to \nin Article 10(8) of the EU Regulation, \n\nfails to store and keep the UDI of a device referred to in Article \n27(8) of the EU Regulation which he or she has supplied or with \nwhich he or she has been supplied, \n\nfails to update the data in relation to a device for which it is \nresponsible in the electronic system referred to in Article 30 of \nthe EU Regulation within one week of a change occurring in \nrelation to information referred to in Article 31(1) of the EU \nRegulation, \n\nfails, within one year of submission or every second year \nthereafter, to confirm the accuracy of the information in the \nelectronic system in accordance with Article 31(1) of the EU \nRegulation in relation to a device for which it is responsible, \n\nfails to make documentation or information available to the \nAuthority in accordance with a request under Article 93(3)(a) of \nthe EU Regulation, \n\nfails to provide a sample of, or access free of charge to, a device \nin accordance with a request under Article 93(3)(a) of the EU \nRegulation, \n\nfails to allow the Authority access to his or her premises for the \npurposes of an inspection under Article 93(3)(b) of the EU \nRegulation, \n\nfails to cooperate with the Authority in relation to the evaluation, \nunder Article 94 of the EU Regulation, of a device for which it is \nresponsible, \n\nfails to take corrective action required by the Authority under \nArticle 95 of the EU Regulation, \n\nfails to bring to an end a non-compliance with the EU Regulation, \nin accordance with a request by the Authority under Article 97 of \nthe EU Regulation, \n\nis guilty of an offence. \n\nOffences by notified bodies", "text_norm": "20 subject regulation 40 economic operator who-- (a) (b) (c) (d) (e) (f) (g) (h) (i) (j) fails identify person institution referred article 25(2) eu regulation period referred article 10(8) eu regulation fails store keep udi device referred article 27(8) eu regulation supplied supplied fails update data relation device responsible electronic system referred article 30 eu regulation within one week change occurring relation information referred article 31(1) eu regulation fails within one year submission every second year thereafter confirm accuracy information electronic system accordance article 31(1) eu regulation relation device responsible fails make documentation information available authority accordance request article 93(3)(a) eu regulation fails provide sample access free charge device accordance request article 93(3)(a) eu regulation fails allow authority access premise purpose inspection article 93(3)(b) eu regulation fails cooperate authority relation evaluation article 94 eu regulation device responsible fails take corrective action required authority article 95 eu regulation fails bring end non-compliance eu regulation accordance request authority article 97 eu regulation guilty offence offence notified body", "start_char": 35987, "end_char": 37873, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-21", "parent_doc_id": "si-2021-0261", "section_id": "reg-21", "section_label": "Regulation 21.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "21. Subject to Regulation 40, a notified body which—", "text_raw": "21. Subject to Regulation 40, a notified body which— \n\n(a) \n\nfails to comply with the requirements of Article 36(1) of the EU \nRegulation, \n\n \n \n \n\f[261] 19 \n\n(b) \n\n(c) \n\n(d) \n\n(e) \n\n(f) \n\n(g) \n\n(h) \n\n(i) \n\n(j) \n\n(k) \n\n(l) \n\n(m) \n\n(n) \n\nfails, where requested, to make available and submit relevant \ndocumentation to the Authority in accordance with Article 36(2) \nof the EU Regulation, \n\ndelegates specific tasks connected with conformity assessment to \na subcontractor or subsidiary which does not meet the applicable \nrequirements set out in Annex VII to the EU Regulation, \n\nfails to inform the Authority, pursuant to Article 37(1) of the EU \nRegulation, that a subcontractor or subsidiary is carrying out \nspecific tasks connected with conformity assessment on its \nbehalf, \n\nfails to make publicly available a list of its subsidiaries in \naccordance with Article 37(3) of the EU Regulation, \n\nfails to inform an applicant for conformity assessment, pursuant \nto Article 37(4) of the EU Regulation, that conformity assessment \nactivities will be carried out by a subcontractor or subsidiary, \n\nfails to keep at the disposal of the Authority, pursuant to Article \n37(5) of the EU Regulation, all relevant documents concerning \nthe verification of the qualifications of a subcontractor or \nsubsidiary carrying out \ntasks connected with conformity \nassessment on its behalf and the tasks carried out by the \nsubcontractor or subsidiary, \n\nfails to inform the Authority, pursuant to Article 38(3) of the EU \nRegulation, of a relevant change in the documentation referred to \nin Article 38(2) of the EU Regulation, \n\nfails to inform the Authority within 15 days, pursuant to Article \n44(1) of the EU Regulation, of a relevant change which may \naffect its compliance with the requirements set out in Annex VII \nto the EU Regulation or its ability to conduct the conformity \nassessment activities relating to the devices for which it has been \ndesignated, \n\nfails to comply with a request by the Authority to supply \ninformation and documents pursuant to Article 44(2) of the EU \nRegulation, \n\nfails to comply with a request by the Commission or the authority \nof a member state other than the State, pursuant to Article 44(3) \nof the EU Regulation, within 15 days of such request, \n\nfails to inform the Authority, in accordance with Article 46(3) of \nthe EU Regulation, that it intends to cease conformity assessment \nactivities, \n\nfails to inform a manufacturer concerned that the notified body’s \ndesignation has been suspended, restricted or fully or partially \nwithdrawn pursuant to Article 46(4) of the EU Regulation, \n\nfails to suspend or withdraw an unduly issued certificate in \naccordance with a request by the Authority under Article 46(4) of \nthe EU Regulation, \n\n \n\f20 [261] \n\n(o) \n\n(p) \n\n(q) \n\n(r) \n\n(s) \n\n(t) \n\nfails to make publicly available, in accordance with Article 50 of \nthe EU Regulation, a list of its standard fees for the conformity \nassessment activities that it carries out, \n\nfails to notify the competent authorities, through the electronic \nsystem referred to in Article 57 of the EU Regulation, of a \ncertificate it has granted to a device in respect of which it has \nperformed a conformity assessment, in accordance with Article \n55(4) of the EU Regulation, \n\nfails to take appropriate action to address the failure of a \nmanufacturer to meet the requirements of the EU Regulation, in \naccordance with Article 56(4) of the EU Regulation, \n\nfails to enter in the electronic system referred to in Article 57 of \nthe EU Regulation the information referred to in Article 56(5) of \nthe EU Regulation regarding a certificate it has issued, \n\nenters into a contract with a manufacturer which is changing \nnotified bodies without executing an agreement in compliance \nwith Article 58(1) of the EU Regulation, \n\nfails to withdraw, in accordance with Article 58(2) of the EU \nRegulation, a certificate it issued which has become invalid in the \ncontext of the termination of the contract with the manufacturer, \n\nis guilty of an offence. \n\nOffences by health institutions", "text_norm": "21 subject regulation 40 notified body which-- (a) fails comply requirement article 36(1) eu regulation 261 19 (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) (m) (n) fails requested make available submit relevant documentation authority accordance article 36(2) eu regulation delegate specific task connected conformity assessment subcontractor subsidiary meet applicable requirement set annex vii eu regulation fails inform authority pursuant article 37(1) eu regulation subcontractor subsidiary carrying specific task connected conformity assessment behalf fails make publicly available list subsidiary accordance article 37(3) eu regulation fails inform applicant conformity assessment pursuant article 37(4) eu regulation conformity assessment activity carried subcontractor subsidiary fails keep disposal authority pursuant article 37(5) eu regulation relevant document concerning verification qualification subcontractor subsidiary carrying task connected conformity assessment behalf task carried subcontractor subsidiary fails inform authority pursuant article 38(3) eu regulation relevant change documentation referred article 38(2) eu regulation fails inform authority within 15 day pursuant article 44(1) eu regulation relevant change may affect compliance requirement set annex vii eu regulation ability conduct conformity assessment activity relating device designated fails comply request authority supply information document pursuant article 44(2) eu regulation fails comply request commission authority member state state pursuant article 44(3) eu regulation within 15 day request fails inform authority accordance article 46(3) eu regulation intends cease conformity assessment activity fails inform manufacturer concerned notified body designation suspended restricted fully partially withdrawn pursuant article 46(4) eu regulation fails suspend withdraw unduly issued certificate accordance request authority article 46(4) eu regulation 20 261 (o) (p) (q) (r) (s) (t) fails make publicly available accordance article 50 eu regulation list standard fee conformity assessment activity carry fails notify competent authority electronic system referred article 57 eu regulation certificate granted device respect performed conformity assessment accordance article 55(4) eu regulation fails take appropriate action address failure manufacturer meet requirement eu regulation accordance article 56(4) eu regulation fails enter electronic system referred article 57 eu regulation information referred article 56(5) eu regulation regarding certificate issued enters contract manufacturer changing notified body without executing agreement compliance article 58(1) eu regulation fails withdraw accordance article 58(2) eu regulation certificate issued become invalid context termination contract manufacturer guilty offence offence health institution", "start_char": 37873, "end_char": 41969, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-22", "parent_doc_id": "si-2021-0261", "section_id": "reg-22", "section_label": "Regulation 22.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "22. Subject to Regulation 40, a health institution which—", "text_raw": "22. Subject to Regulation 40, a health institution which— \n\n(a) manufactures and uses an in-house device which is not in \ncompliance with the relevant general safety and performance \nrequirements set out in Annex I to the EU Regulation, \n\n(b) \n\nfails to comply with Regulation 6, \n\n(c) \n\nfails to comply with a condition in Article 5(5) of the EU \nRegulation in respect of an in-house device which it manufactures \nand uses, or \n\n(d) \n\nfails to store and keep the UDI of a class III implantable device \nwhich it has supplied or with which it has been supplied, \n\nis guilty of an offence. \n\nOffences by sponsors", "text_norm": "22 subject regulation 40 health institution which-- (a) manufacture us in-house device compliance relevant general safety performance requirement set annex eu regulation (b) fails comply regulation 6 (c) fails comply condition article 5(5) eu regulation respect in-house device manufacture us (d) fails store keep udi class iii implantable device supplied supplied guilty offence offence sponsor", "start_char": 41969, "end_char": 42582, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-23", "parent_doc_id": "si-2021-0261", "section_id": "reg-23", "section_label": "Regulation 23.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "23. (1) Subject to paragraphs (3) to (7) and Regulation 40, a sponsor who,", "text_raw": "23. (1) Subject to paragraphs (3) to (7) and Regulation 40, a sponsor who, \nin respect of a clinical investigation to be, or being, conducted in the State, for \nwhich the sponsor is responsible— \n\n(a) \n\nfails to ensure that the clinical investigation is designed, \nauthorised, conducted, recorded and reported in accordance with \nArticle 62(1) of the EU Regulation, where applicable, \n\n \n \n \n\f[261] 21 \n\n(b) \n\n(c) \n\n(d) \n\n(e) \n\n(f) \n\n(g) \n\n(h) \n\n(i) \n\n(j) \n\n(k) \n\n(l) \n\nfails to ensure that the clinical investigation is designed and \nconducted in accordance with Article 62(3) of the EU Regulation, \n\nfails to ensure that all of the conditions listed in Article 62(4) of \nthe EU Regulation are met, \n\nfails to submit to the Authority a copy of an opinion of a National \nREC in respect of a clinical investigation in accordance with \nRegulation 11, \n\nstarts the clinical investigation otherwise than in accordance with \nArticle 70(7) of the EU Regulation and Regulation 13, \n\nfails to ensure that the clinical investigation is conducted in \naccordance with the approved clinical investigation plan, \n\nfails to ensure adequate monitoring of the conduct of the clinical \ninvestigation in accordance with Article 72(2) of the EU \nRegulation, \n\nfails to ensure that information in relation to the clinical \ninvestigation is recorded, processed, handled and stored in \naccordance with Article 72(3) of the EU Regulation, \n\nfails to inform the Authority of the temporary halting or early \ntermination of the clinical investigation in accordance with \nArticle 77(1) of the EU Regulation, \n\nfails to notify the Authority of the end of the clinical investigation \nin accordance with Article 77(3) or (4) of the EU Regulation, \n\nfails to submit a clinical investigation report in accordance with \nArticle 77(5) of the EU Regulation, \n\nfails to record information referred to in Article 80(1) of the EU \nRegulation in relation to an adverse event, or \n\n(m) \n\nfails to report to the Authority the information referred to in \nArticle 80(2) of the EU Regulation in relation to a serious adverse \nevent, in accordance with that provision or Article 80(3) or (4) of \nthe EU Regulation, as applicable, \n\nis guilty of an offence. \n\n(2) A sponsor of a clinical investigation in the State who is not established \nin the European Economic Area is guilty of an offence where he or she fails to \nensure that a natural or legal person is established in the European Economic \nArea as its legal representative (“legal representative”) in accordance with \nArticle 62(2) of the EU Regulation, \n\n(3) Where a legal representative has been appointed in accordance with \nArticle 62(2), the offences listed in paragraph (1) apply to the legal \nrepresentative in place of the sponsor. \n\n(4) A sponsor or legal representative, as the case may be, is not guilty of an \noffence under paragraph (1) by reason of the failure to ensure compliance with \nArticle 62(4)(f), 63, 64(1)(a) or (b) or 65(1)(a) or (b) of the EU Regulation where \nan emergency situation derogation under Article 68(1) of the EU Regulation \n\n \n\f22 [261] \n\napplies and the relevant requirements of Article 68(2) and (3) of the EU \nRegulation are met. \n\n(5) In the case of a clinical investigation coming within the scope of Article \n74(1) of the EU Regulation (“PMCF investigation”), which is considered \nnotifiable to the Authority, the offences in paragraph (1) shall not apply, other \nthan those at subparagraphs (i), (j) and (k) thereof, and the sponsor or legal \nrepresentative of the clinical investigation is, in addition, guilty of an offence \nwhere it— \n\n(a) \n\n(b) \n\nfails to ensure that the conditions listed in Article 62(4)(b) to (k) \nand (m) of the EU Regulation are met, or \n\nfails to ensure that the provisions on vigilance laid down in \nArticles 87 to 90 of the EU Regulation are complied with. \n\n(6) Notwithstanding paragraph (5), the offences in paragraph (1)(l) and (m) \nshall apply to the sponsor or legal representative of a PMCF investigation where \na causal relationship between the serious adverse event and the preceding \ninvestigational procedure has been established. \n\n(7) In the case of a clinical investigation referred to in Regulation 14(1), the \noffences in paragraph (1) shall not apply, but the sponsor or legal representative \nof the clinical investigation is guilty of an offence where it fails to ensure \ncompliance with— \n\n(a) \n\n(b) \n\nthe requirements of Article 82(1) of the EU Regulation, or \n\nthe requirements listed in Regulation 14(2). \n\nOffences - general", "text_norm": "23 (1) subject paragraph (3) (7) regulation 40 sponsor respect clinical investigation conducted state sponsor responsible-- (a) fails ensure clinical investigation designed authorised conducted recorded reported accordance article 62(1) eu regulation applicable 261 21 (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) fails ensure clinical investigation designed conducted accordance article 62(3) eu regulation fails ensure condition listed article 62(4) eu regulation met fails submit authority copy opinion national rec respect clinical investigation accordance regulation 11 start clinical investigation otherwise accordance article 70(7) eu regulation regulation 13 fails ensure clinical investigation conducted accordance approved clinical investigation plan fails ensure adequate monitoring conduct clinical investigation accordance article 72(2) eu regulation fails ensure information relation clinical investigation recorded processed handled stored accordance article 72(3) eu regulation fails inform authority temporary halting early termination clinical investigation accordance article 77(1) eu regulation fails notify authority end clinical investigation accordance article 77(3) (4) eu regulation fails submit clinical investigation report accordance article 77(5) eu regulation fails record information referred article 80(1) eu regulation relation adverse event (m) fails report authority information referred article 80(2) eu regulation relation serious adverse event accordance provision article 80(3) (4) eu regulation applicable guilty offence (2) sponsor clinical investigation state established european economic area guilty offence fails ensure natural legal person established european economic area legal representative ( legal representative ) accordance article 62(2) eu regulation (3) legal representative appointed accordance article 62(2) offence listed paragraph (1) apply legal representative place sponsor (4) sponsor legal representative case may guilty offence paragraph (1) reason failure ensure compliance article 62(4)(f) 63 64(1)(a) (b) 65(1)(a) (b) eu regulation emergency situation derogation article 68(1) eu regulation 22 261 applies relevant requirement article 68(2) (3) eu regulation met (5) case clinical investigation coming within scope article 74(1) eu regulation ( pmcf investigation ) considered notifiable authority offence paragraph (1) shall apply subparagraphs (i) (j) (k) thereof sponsor legal representative clinical investigation addition guilty offence it-- (a) (b) fails ensure condition listed article 62(4)(b) (k) (m) eu regulation met fails ensure provision vigilance laid article 87 90 eu regulation complied with (6) notwithstanding paragraph (5) offence paragraph (1)(l) (m) shall apply sponsor legal representative pmcf investigation causal relationship serious adverse event preceding investigational procedure established (7) case clinical investigation referred regulation 14(1) offence paragraph (1) shall apply sponsor legal representative clinical investigation guilty offence fails ensure compliance with-- (a) (b) requirement article 82(1) eu regulation requirement listed regulation 14(2) offence - general", "start_char": 42582, "end_char": 47118, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-24", "parent_doc_id": "si-2021-0261", "section_id": "reg-24", "section_label": "Regulation 24.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "24. Subject to Regulation 40, a person who—", "text_raw": "24. Subject to Regulation 40, a person who— \n\n(a) makes available on the market or puts into service a device which \nfails to comply with a general safety and performance \nrequirement under Annex I to the EU Regulation which applies \nto it taking into account its intended purpose, \n\n(b) makes available on the market or puts into service a combination \nproduct the device part of which does not comply with the \nrelevant general safety and performance requirements set out in \nAnnex I to the EU Regulation, \n\n(c) \n\noffers by means of information society services, to a natural or \nlegal person established in a member state, a device which is not \nin compliance with the EU Regulation, \n\n(d) uses in the context of a commercial activity, whether in return for \npayment or free of charge, for the provision of a diagnostic or \ntherapeutic service offered by means of information society \nservices or by other means of communication, directly or through \nintermediaries, to a natural or legal person established in a \nmember state, a device which is not in compliance with the EU \nRegulation, \n\n \n \n\f[261] 23 \n\n(e) \n\n(f) \n\n(g) \n\noffers a device by means of information society services in \naccordance with Article 6(1) of the EU Regulation, or provides a \nservice in accordance with Article 6(2) of the EU Regulation, and \nfails to make available to the Authority on request a copy of the \nEU declaration of conformity of the device, \n\nfails to comply with a request by the Authority pursuant to Article \n6(4) of the EU Regulation to cease providing information society \nservices, \n\nin the labelling, instructions for use, making available, putting \ninto service or advertising of a device, uses text, names, \ntrademarks, pictures or figurative or other signs that may mislead \nthe user or the patient contrary to Article 7 of the EU Regulation, \n\n(h) makes available on the market a custom-made device which is not \naccompanied by the statement referred to in Section 1 of Annex \nXIII to the EU Regulation, \n\n(i) \n\n(j) \n\n(k) \n\ncombines a device bearing a CE marking with a device or product \nlisted in Article 22(1) of the EU Regulation in the manner referred \nto in that provision without drawing up a statement in accordance \nwith Article 22(2) of the EU Regulation, \n\nsterilises systems or procedure packs referred to in Article 22(1) \nof the EU Regulation without complying with Article 22(3) of the \nEU Regulation, \n\nhaving made a statement referred to in Article 22(2) of the EU \nRegulation, fails to keep it available for the Authority in \naccordance with Articles 22(5) and 10(8) of the EU Regulation, \n\n(l) makes available on the market an item, specifically intended to \nreplace an identical or similar integral part or component of a \ndevice in the circumstances referred to in Article 23(1) of the EU \nRegulation, which adversely affects the safety and performance \nof the device, \n\n(m) having made available on the market an item referred to in Article \n23(1) of the EU Regulation, fails to keep supporting evidence of \ncompliance with that provision available for the Authority, \n\n(n) places on the market a system or procedure pack pursuant to \nArticle 22(1) and (3) of the EU Regulation, that is not a custommade device, without first assigning to the system or procedure \npack a Basic UDI-DI \n\n(o) places on the market a system or procedure pack pursuant to \nArticle 22(1) and (3) of the EU Regulation, that is not a custommade device, without providing the Basic UDI-DI to the UDI \ndatabase, in accordance with Article 29(2) of the EU Regulation, \n\n(p) places on the market, or puts into service, a device that has not \nbeen the subject of a conformity assessment in accordance with \nArticle 52 of the EU Regulation or which has not been subject of \na derogation granted under Article 59 of the EU Regulation, \n\n \n\f24 [261] \n\n(q) \n\n(r) \n\n(s) \n\n(t) \n\n(u) \n\n(v) \n\nfails to comply with a request, notice or order made under these \nRegulations, \n\nin purported compliance with a request, notice or order under \nthese Regulations gives information to the Authority or an \nauthorised officer that he or she knows to be false or misleading \nin any material respect, \n\nobstructs or interferes with the Authority, an authorised officer, a \nmember of An Garda Síochána or a person with expertise relating \nto any relevant thing, in the course of performing a function \nconferred on him, her or it by these Regulations, \n\nfalsely represents himself or herself to be an authorised officer \nunder these Regulations, \n\nimpedes the performance by a person referred to in paragraph (s) \nof such function, or fails or refuses to comply with a request or \nrequirement of, or to answer a question asked by such person, \n\ndiscloses any confidential information to which he or she has \naccess by virtue of these Regulations, otherwise than in \naccordance with these Regulations, \n\n(w) discloses or uses for business or commercial purposes or any \nother purpose any information relating to a CE marking approval \napplication in the possession of a notified body without the \nconsent of that body, \n\n(x) \n\nfails to take reasonable measures to guarantee confidentiality with \nregard to forwarding any documentation required under these \nRegulations, \n\n(y) makes a false document or possesses or uses a document knowing \nit to be false or purporting to be issued, granted, given or required \nunder this Regulation or the EU Regulation (“a false document”), \n\n(z) \n\nalters with intent to defraud or deceive, or uses knowing it to be \nso altered, a document issued, granted, given or required under \nthis Regulation or the EU Regulation (“an altered document”), \n\n(aa) without lawful authority, has in his or her possession a false \n\ndocument or an altered document, \n\n(bb) tampers with any substance or device, or parts, material or \naccessory designated to be used as part of or with a device, \n\n(cc) \n\ntampers or interferes with any sample taken under Regulation \n29(3)(i) or (j), \n\n(dd) being a supplier of a device, or a subcontractor of a manufacturer, \nfails to allow the Authority access to his or her premises for the \npurposes of an inspection under Article 93(3)(b) of the EU \nRegulation, \n\n(ee) being a professional user of a device, fails to allow the Authority \naccess to his or her facilities for the purpose of a necessary \ninspection under Article 93(3)(b) of the EU Regulation, or \n\n \n\f[261] 25 \n\n(ff) \n\nreprocesses a single-use device to make it suitable for further use \nwithin a member state otherwise than in accordance with \nRegulation 7. \n\nis guilty of an offence. \n\nProvisions related to offences", "text_norm": "24 subject regulation 40 person who-- (a) make available market put service device fails comply general safety performance requirement annex eu regulation applies taking account intended purpose (b) make available market put service combination product device part comply relevant general safety performance requirement set annex eu regulation (c) offer mean information society service natural legal person established member state device compliance eu regulation (d) us context commercial activity whether return payment free charge provision diagnostic therapeutic service offered mean information society service mean communication directly intermediary natural legal person established member state device compliance eu regulation 261 23 (e) (f) (g) offer device mean information society service accordance article 6(1) eu regulation provides service accordance article 6(2) eu regulation fails make available authority request copy eu declaration conformity device fails comply request authority pursuant article 6(4) eu regulation cease providing information society service labelling instruction use making available putting service advertising device us text name trademark picture figurative sign may mislead user patient contrary article 7 eu regulation (h) make available market custom-made device accompanied statement referred section 1 annex xiii eu regulation (i) (j) (k) combine device bearing ce marking device product listed article 22(1) eu regulation manner referred provision without drawing statement accordance article 22(2) eu regulation sterilises system procedure pack referred article 22(1) eu regulation without complying article 22(3) eu regulation made statement referred article 22(2) eu regulation fails keep available authority accordance article 22(5) 10(8) eu regulation (l) make available market item specifically intended replace identical similar integral part component device circumstance referred article 23(1) eu regulation adversely affect safety performance device (m) made available market item referred article 23(1) eu regulation fails keep supporting evidence compliance provision available authority (n) place market system procedure pack pursuant article 22(1) (3) eu regulation custommade device without first assigning system procedure pack basic udi-di (o) place market system procedure pack pursuant article 22(1) (3) eu regulation custommade device without providing basic udi-di udi database accordance article 29(2) eu regulation (p) place market put service device subject conformity assessment accordance article 52 eu regulation subject derogation granted article 59 eu regulation 24 261 (q) (r) (s) (t) (u) (v) fails comply request notice order made regulation purported compliance request notice order regulation give information authority authorised officer know false misleading material respect obstructs interferes authority authorised officer member garda siochana person expertise relating relevant thing course performing function conferred regulation falsely represents authorised officer regulation impedes performance person referred paragraph (s) function fails refuse comply request requirement answer question asked person discloses confidential information access virtue regulation otherwise accordance regulation (w) discloses us business commercial purpose purpose information relating ce marking approval application possession notified body without consent body (x) fails take reasonable measure guarantee confidentiality regard forwarding documentation required regulation (y) make false document posse us document knowing false purporting issued granted given required regulation eu regulation ( false document ) (z) alters intent defraud deceive us knowing altered document issued granted given required regulation eu regulation ( altered document ) (aa) without lawful authority possession false document altered document (bb) tamper substance device part material accessory designated used part device (cc) tamper interferes sample taken regulation 29(3)(i) (j) (dd) supplier device subcontractor manufacturer fails allow authority access premise purpose inspection article 93(3)(b) eu regulation (ee) professional user device fails allow authority access facility purpose necessary inspection article 93(3)(b) eu regulation 261 25 (ff) reprocesses single-use device make suitable use within member state otherwise accordance regulation 7 guilty offence provision related offence", "start_char": 47118, "end_char": 53732, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-25", "parent_doc_id": "si-2021-0261", "section_id": "reg-25", "section_label": "Regulation 25.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "25. (1) For the purpose of these Regulations, every contravention of a", "text_raw": "25. (1) For the purpose of these Regulations, every contravention of a \nprovision of these Regulations shall be deemed a separate contravention and \nevery contravention of a paragraph or a subparagraph of such provision shall \nalso be deemed to be a separate contravention and shall carry the same penalty \nas for a single contravention of any such provision. \n\n(2) Where a person is convicted of an offence under these Regulations, the \ncourt shall, unless it is satisfied that there are special and substantial reasons for \nnot doing so, order the person to pay to the Authority the costs and expenses, \nmeasured by the court, incurred by the Authority, in relation to the investigation, \ndetection and prosecution of the offence, including costs and expenses incurred \nin the taking of samples, the carrying out of tests, examinations and analyses and \nin respect of the remuneration and other expenses of employees, consultants and \nadvisors engaged by the Authority. \n\n(3) On conviction for an offence under these Regulations, the court may, in \n\naddition to any other penalty or cost— \n\n(a) order any relevant thing or any vehicle, vessel or container to \nwhich the offence relates to be forfeited to the Authority for \ndestruction or disposal as the Authority thinks fit, and \n\n(b) upon application made to it by or on behalf of the Authority, order \nthe person convicted of the offence to pay to the Authority all or \npart of the costs of the destruction or disposal of such relevant \nthing or any vehicle, vessel or container, subject to such \nconditions, if any, as specified in the order. \n\n(4) An order for costs and expenses under paragraph (2) or (3) is in addition \n\nto, and not instead of, any fine or penalty the court may impose. \n\n(5) In any proceedings for an offence under these Regulations, where no \nconviction is recorded, the court may, upon application made to it by or on behalf \nof the Authority, order any relevant thing to which the offence relates to be \nforfeited to the Authority for destruction or disposal. \n\nProceedings", "text_norm": "25 (1) purpose regulation every contravention provision regulation shall deemed separate contravention every contravention paragraph subparagraph provision shall also deemed separate contravention shall carry penalty single contravention provision (2) person convicted offence regulation court shall unless satisfied special substantial reason order person pay authority cost expense measured court incurred authority relation investigation detection prosecution offence including cost expense incurred taking sample carrying test examination analysis respect remuneration expense employee consultant advisor engaged authority (3) conviction offence regulation court may addition penalty cost-- (a) order relevant thing vehicle vessel container offence relates forfeited authority destruction disposal authority think fit (b) upon application made behalf authority order person convicted offence pay authority part cost destruction disposal relevant thing vehicle vessel container subject condition specified order (4) order cost expense paragraph (2) (3) addition instead fine penalty court may impose (5) proceeding offence regulation conviction recorded court may upon application made behalf authority order relevant thing offence relates forfeited authority destruction disposal proceeding", "start_char": 53732, "end_char": 55790, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-26", "parent_doc_id": "si-2021-0261", "section_id": "reg-26", "section_label": "Regulation 26.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "26. (1) Proceedings in relation to a summary offence under these", "text_raw": "26. (1) Proceedings in relation to a summary offence under these \n\nRegulations may be brought and prosecuted by the Authority. \n\n(2) In proceedings for an offence under these Regulations, a certificate or \nreport signed by an approved examiner stating the results of any test, \nexamination or analysis of a sample shall, with regard to that sample, be evidence \nof the matters stated in the certificate or report unless the contrary is proved. \n\n \n \n \n\f26 [261] \n\n(3) In proceeding for an offence under these Regulations, a relevant thing, \nor package containing a relevant thing, that purports to bear the name of the \nmanufacturer or importer of that thing, or of the person who made that thing \navailable on the market, shall, unless the contrary is proved, be evidence that the \nrelevant thing was manufactured or imported, or made available on the market, \nas the case may be, by the person so named. \n\nPART 4 \n\nCOMPLIANCE AND ENFORCEMENT \n\nEnforcement generally", "text_norm": "26 (1) proceeding relation summary offence regulation may brought prosecuted authority (2) proceeding offence regulation certificate report signed approved examiner stating result test examination analysis sample shall regard sample evidence matter stated certificate report unless contrary proved 26 261 (3) proceeding offence regulation relevant thing package containing relevant thing purport bear name manufacturer importer thing person made thing available market shall unless contrary proved evidence relevant thing manufactured imported made available market case may person named part 4 compliance enforcement enforcement generally", "start_char": 55790, "end_char": 56760, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-27", "parent_doc_id": "si-2021-0261", "section_id": "reg-27", "section_label": "Regulation 27.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "27. (1) These Regulations, and the provisions of the EU Regulation to which", "text_raw": "27. (1) These Regulations, and the provisions of the EU Regulation to which \n\nthey refer, shall be enforced by the Authority. \n\n(2) In carrying out its compliance and enforcement role under the EU \nRegulation and these Regulations, the Authority shall adhere to the principle of \ngood administrative practice, as provided for in Article 99 of the EU Regulation. \n\nAuthorised officers", "text_norm": "27 (1) regulation provision eu regulation refer shall enforced authority (2) carrying compliance enforcement role eu regulation regulation authority shall adhere principle good administrative practice provided article 99 eu regulation authorised officer", "start_char": 56760, "end_char": 57146, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-28", "parent_doc_id": "si-2021-0261", "section_id": "reg-28", "section_label": "Regulation 28.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "28. (1) For the purposes of ensuring compliance with the EU Regulation and", "text_raw": "28. (1) For the purposes of ensuring compliance with the EU Regulation and \n\nthese Regulations, the chief executive of the Authority— \n\n(a) may appoint such and so many persons as he or she thinks fit to \n\nbe authorised officers for the purpose of these Regulations, and \n\n(b) \n\nshall furnish each authorised officer appointed by him or her with \na warrant of the authorised officer’s appointment. \n\n(2) An authorised officer, other than an authorised officer who is an officer \nof Customs and Excise, shall, when performing a function imposed under these \nRegulations on an authorised officer, produce his or her warrant for inspection \nif requested to do so by a person affected by the performance of that function. \n\n(3) For the purposes of ensuring compliance with the EU Regulation or the \n\nMarket Surveillance Regulation, an authorised officer may— \n\n(a) \n\nsubject to paragraph (5), enter (if necessary by the use of \nreasonable force), at all reasonable times, any premises at which \nhe or she has reasonable grounds for believing that— \n\n(i) \n\nany \nthe \ntrade, business or activity connected with \nmanufacture, processing, sterilisation, disposal, export, \nimport, distribution, sale, supply, storage, packaging, \nlabelling, preparation, professional use, conformity \nassessment, or advertising of any relevant thing or the \nprocessing of financial transactions in relation to the \nrelevant thing is or has been carried on, or \n\n \n \n \n \n \n\f[261] 27 \n\n(ii) books, records or other documents (including documents \nstored in non-legible form) relating to such trade, business \nor activity or the processing of financial transactions in \nrelation to the relevant thing are kept, \n\n(b) \n\n(c) \n\nat such premises inspect and take copies of, any books, records, \nother documents (including documents stored in non-legible \nform) or extracts therefrom, which he or she finds in the course \nof his or her inspection, \n\nremove any such books, records or other documents from such \npremises and detain them for such period as he or she reasonably \nconsiders to be necessary for the purposes of his or her functions \nunder these Regulations, \n\n(d) \n\ncarry out, or have carried out, such tests, examinations, analyses, \ninspections and checks of— \n\n(i) \n\nthe premises, \n\n(ii) any relevant thing at the premises, or \n\n(e) \n\n(f) \n\n(g) \n\n(iii) any equipment, machinery or plant at the premises, \n\nas he or she reasonably considers to be necessary for the purposes \nof his or her functions under these Regulations, \n\nrequire any person at the premises, the owner or person in charge \nof the premises or any person employed there to give to him or \nher such assistance and information and to produce to him or her \nsuch books, records or other documents (and in the case of \ndocuments or records stored in non-legible form, produce to him \nor her a legible reproduction thereof) that are in that person’s \npower or procurement, as he or she may reasonably require for \nthe purposes of his or her functions under these Regulations, \n\npurchase or take without payment a sample of any relevant thing \nfound at the premises for the purposes of any test, examination or \nanalysis, \n\nsecure and detain for later inspection any premises or part of any \npremises in which a relevant thing is found or ordinarily kept, or \nbooks, records or other documents are found or ordinarily kept, \nfor such period as may reasonably be necessary for the purposes \nof his or her functions under these Regulations, \n\n(h) without payment, take possession of and remove from the \npremises for any test, examination or analysis any relevant thing \nfound there, and detain it for such period as he or she considers \nreasonably necessary for the purposes of his or her functions \nunder these Regulations, \n\n(i) without payment, take samples of any relevant thing detained \npursuant to subparagraph (j), for the purposes of any test, \nexamination, or analysis, \n\n \n\f28 [261] \n\n(j) where the taking of samples of any relevant thing pursuant to \nsubparagraph (f) or (i) is, for whatever reason, not practicable, \npurchase or take without payment the relevant thing concerned \nfor the purposes of any test, examination or analysis, or carry out \ntesting, examination or analysis of the relevant thing at the \npremises, \n\n(k) \n\nstop any person, vehicle, vessel or container at the premises, \n\n(l) \n\nboard and search any such vehicle, vessel or container, \n\n(m) \n\nrequire the name and address of any person on the premises, \n\n(n) make a record whether in writing, by photography or otherwise, \n\n(o) \n\n(p) \n\n(q) \n\ninspect and copy or extract information from any data within the \nmeaning of the Data Protection Acts 1988 to 2018, \n\nrequire a person, having authority to do so, to break open any \ncontainer, receptacle or package, or to open any vending machine, \nor to permit him or her to do so, as he or she may reasonably \nrequire for the purposes of his or her functions under these \nRegulations, \n\nrequire a person, who makes available facilities such as post \noffice boxes, telecommunications, financial payment services, \nelectronic mail addresses or other like facilities, to give him or \nher such assistance and information as he or she may reasonably \nrequire for the purposes of his or her functions under these \nRegulations in any case where the officer has reasonable grounds \nfor believing that any relevant thing is being supplied by \ninformation society services or mail order, or in contravention of \nany provision of these Regulations or the EU Regulation relating \nto any trade, business or activity referred to in subparagraph (a)(i), \nor books, records or documents referred to in subparagraph (a)(ii), \nor \n\n(r) where no other effective means are available to eliminate a \n\nserious risk— \n\n(i) \n\nrequire the removal of content referring to devices and \nrelated products from an online interface or require the \nexplicit display of a warning to end users when they access \nan online interface, or \n\n(ii) where a request under clause (i) has not been complied with, \nrequire information society service providers to restrict \naccess to the online interface, including by requesting a \nrelevant third party to implement such measures. \n\n(4) When performing a function under these Regulations, an authorised \nofficer may, subject to any warrant under paragraph (6), be accompanied by such \nnumber of— \n\n(a) other authorised officers, \n\n(b) members of An Garda Síochána, or \n\n \n\f[261] 29 \n\n(c) \n\npersons with expertise relating to any relevant thing, \n\nas he or she considers appropriate in the circumstances of the case. \n\n(5) An authorised officer shall not enter a dwelling, other than— \n\n(a) with the consent of the occupier, or \n\n(b) \n\nin accordance with a warrant issued under paragraph (6). \n\n(6) Upon the application of an authorised officer, a judge of the District \n\nCourt, if satisfied that there are reasonable grounds for believing that— \n\n(a) \n\n(b) \n\n(c) \n\na relevant thing is to be found in any dwelling, or is being or has \nbeen subjected to any process or stored in any dwelling, \n\na dwelling is occupied in whole or in part by an undertaking \nengaged in any trade, business or activity referred to in paragraph \n(3)(a)(i), or \n\nbooks, records or other documents (including documents stored \nin non-legible form) referred to in paragraph (3)(a)(ii) are being \nstored or kept in any dwelling, \n\nmay issue a warrant authorising a named authorised officer accompanied by such \nother authorised officers, members of An Garda Síochána, or persons with \nexpertise relating to any relevant thing, as may be necessary, at any time or times, \nwithin one month of the date of issue of the warrant, to enter the dwelling and \nperform any of the functions of an authorised officer under paragraph (3)(b) to \n(r). \n\n(7) Where an authorised officer, upon reasonable grounds, believes that a \nperson has committed an offence under these Regulations, he or she may require \nthat person to provide him or her with his or her name, date of birth, and the \naddress at which he or she ordinarily resides, and to produce corroborative \nevidence of same. \n\n(8) Where an authorised officer has reasonable cause to suspect that— \n\n(a) \n\n(b) \n\nan offence is being or has been committed under these \nRegulations, or \n\nevidence of an offence or contravention may be, is or has been on \nor in any premises, \n\nthe authorised officer may, in addition to the powers exercisable by him or her \nunder paragraph (3)— \n\n(i) \n\n(ii) \n\nsearch a person, where the authorised officer considers it \nnecessary, \n\nseize and detain a vessel, vehicle, container, equipment, \nmachinery or relevant thing, \n\n(iii) dispose of a relevant thing, or require the owner or person \nin charge of or in possession of a relevant thing to deal with \nor dispose of it (or any other thing used in connection with, \nor that may have been in contact with, the relevant thing) in \na manner that the authorised officer thinks fit. \n\n \n\f30 [261] \n\n(9) An authorised officer may dispose of, or cause to be disposed, a relevant \nthing, or a sample of a relevant thing, taken under this Regulation, in such \nmanner and at such place as the authorised officer considers appropriate in the \ncircumstances of the case. \n\n(10) The costs (including ancillary costs) of any seizure, detention or disposal \ncarried out by the Authority under paragraph (8) or (9) shall be recoverable as a \nsimple contract debt in any court of competent jurisdiction from the relevant \nmanufacturer, distributor, importer or other person responsible for the item \nseized, detained or disposed of. \n\n(11) A statement or admission made by a person pursuant to a requirement \nunder paragraph (3) shall not be admissible as evidence in proceedings brought \nagainst that person for an offence (other than an offence under these Regulations \nfor failing to give information or giving false information). \n\n(12) Nothing in this Regulation shall be taken to compel the production by \nany person of a document which he or she would be exempt from producing in \nproceedings in a court on the ground of legal professional privilege. \n\nTaking of samples", "text_norm": "28 (1) purpose ensuring compliance eu regulation regulation chief executive authority-- (a) may appoint many person think fit authorised officer purpose regulation (b) shall furnish authorised officer appointed warrant authorised officer appointment (2) authorised officer authorised officer officer custom excise shall performing function imposed regulation authorised officer produce warrant inspection requested person affected performance function (3) purpose ensuring compliance eu regulation market surveillance regulation authorised officer may-- (a) subject paragraph (5) enter (if necessary use reasonable force) reasonable time premise reasonable ground believing that-- (i) trade business activity connected manufacture processing sterilisation disposal export import distribution sale supply storage packaging labelling preparation professional use conformity assessment advertising relevant thing processing financial transaction relation relevant thing carried 261 27 (ii) book record document (including document stored non-legible form) relating trade business activity processing financial transaction relation relevant thing kept (b) (c) premise inspect take copy book record document (including document stored non-legible form) extract therefrom find course inspection remove book record document premise detain period reasonably considers necessary purpose function regulation (d) carry carried test examination analysis inspection check of-- (i) premise (ii) relevant thing premise (e) (f) (g) (iii) equipment machinery plant premise reasonably considers necessary purpose function regulation require person premise owner person charge premise person employed give assistance information produce book record document (and case document record stored non-legible form produce legible reproduction thereof) person power procurement may reasonably require purpose function regulation purchase take without payment sample relevant thing found premise purpose test examination analysis secure detain later inspection premise part premise relevant thing found ordinarily kept book record document found ordinarily kept period may reasonably necessary purpose function regulation (h) without payment take possession remove premise test examination analysis relevant thing found detain period considers reasonably necessary purpose function regulation (i) without payment take sample relevant thing detained pursuant subparagraph (j) purpose test examination analysis 28 261 (j) taking sample relevant thing pursuant subparagraph (f) (i) whatever reason practicable purchase take without payment relevant thing concerned purpose test examination analysis carry testing examination analysis relevant thing premise (k) stop person vehicle vessel container premise (l) board search vehicle vessel container (m) require name address person premise (n) make record whether writing photography otherwise (o) (p) (q) inspect copy extract information data within meaning data protection act 1988 2018 require person authority break open container receptacle package open vending machine permit may reasonably require purpose function regulation require person make available facility post office box telecommunication financial payment service electronic mail address like facility give assistance information may reasonably require purpose function regulation case officer reasonable ground believing relevant thing supplied information society service mail order contravention provision regulation eu regulation relating trade business activity referred subparagraph (a)(i) book record document referred subparagraph (a)(ii) (r) effective mean available eliminate serious risk-- (i) require removal content referring device related product online interface require explicit display warning end user access online interface (ii) request clause (i) complied require information society service provider restrict access online interface including requesting relevant third party implement measure (4) performing function regulation authorised officer may subject warrant paragraph (6) accompanied number of-- (a) authorised officer (b) member garda siochana 261 29 (c) person expertise relating relevant thing considers appropriate circumstance case (5) authorised officer shall enter dwelling than-- (a) consent occupier (b) accordance warrant issued paragraph (6) (6) upon application authorised officer judge district court satisfied reasonable ground believing that-- (a) (b) (c) relevant thing found dwelling subjected process stored dwelling dwelling occupied whole part undertaking engaged trade business activity referred paragraph (3)(a)(i) book record document (including document stored non-legible form) referred paragraph (3)(a)(ii) stored kept dwelling may issue warrant authorising named authorised officer accompanied authorised officer member garda siochana person expertise relating relevant thing may necessary time time within one month date issue warrant enter dwelling perform function authorised officer paragraph (3)(b) (r) (7) authorised officer upon reasonable ground belief person committed offence regulation may require person provide name date birth address ordinarily resides produce corroborative evidence same (8) authorised officer reasonable cause suspect that-- (a) (b) offence committed regulation evidence offence contravention may premise authorised officer may addition power exercisable paragraph (3)-- (i) (ii) search person authorised officer considers necessary seize detain vessel vehicle container equipment machinery relevant thing (iii) dispose relevant thing require owner person charge possession relevant thing deal dispose (or thing used connection may contact relevant thing) manner authorised officer think fit 30 261 (9) authorised officer may dispose cause disposed relevant thing sample relevant thing taken regulation manner place authorised officer considers appropriate circumstance case (10) cost (including ancillary costs) seizure detention disposal carried authority paragraph (8) (9) shall recoverable simple contract debt court competent jurisdiction relevant manufacturer distributor importer person responsible item seized detained disposed of (11) statement admission made person pursuant requirement paragraph (3) shall admissible evidence proceeding brought person offence (other offence regulation failing give information giving false information) (12) nothing regulation shall taken compel production person document would exempt producing proceeding court ground legal professional privilege taking sample", "start_char": 57146, "end_char": 67287, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-29", "parent_doc_id": "si-2021-0261", "section_id": "reg-29", "section_label": "Regulation 29.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "29. (1) Subject to paragraph (3), where an authorised officer purchases or", "text_raw": "29. (1) Subject to paragraph (3), where an authorised officer purchases or \ntakes without payment a sample of a relevant thing pursuant to Regulation \n28(3)(i) he or she may, where practicable— \n\n(a) \n\ntake multiple samples, \n\n(b) place each sample into separate containers, and \n\n(c) \n\nforthwith seal and mark each such container in such a manner as \nto identify it as part of the sample taken by the authorised officer. \n\n(2) Where the authorised officer has, sealed and marked a sample of a \n\nrelevant thing in accordance with paragraph (1), he or she shall— \n\n(a) offer one of the sealed containers to the owner or the person for \nthe time being in charge or possession of the relevant thing from \nwhich the sample concerned was taken, \n\n(b) \n\nretain one of the sealed containers, and \n\n(c) \n\nforward, or cause to be forwarded, one of the sealed containers \nfor test, examination or analysis of the sample concerned by an \napproved examiner or where appropriate for examination by the \nAuthority. \n\n(3) Where a relevant thing is contained in a container and, for whatever \nreason, it is not practicable to take multiple samples, an authorised officer, who \nwishes to take samples of such relevant things for the purposes of any tests, \nexamination or analysis may take possession of 3 such containers belonging to \nthe same batch or lot, and each such container shall be deemed to be part of a \nsample for the purposes of paragraph (1), and the provision of paragraphs (1) \nand (2) shall apply thereto accordingly. \n\n \n \n \n\f[261] 31 \n\n(4) Where an authorised officer purchases or takes without payment a \nrelevant thing pursuant to Regulation 28(3)(j) he or she may, where \npracticable— \n\n(a) place the relevant thing in a container, \n\n(b) \n\n(c) \n\nforthwith seal and mark the container in such a manner as to \nidentify it as a relevant thing taken pursuant to that subparagraph, \nand \n\nforward, or cause to be forwarded, the sealed container for test, \nexamination or analysis of the relevant thing by an approved \nexaminer. \n\nProduction order", "text_norm": "29 (1) subject paragraph (3) authorised officer purchase take without payment sample relevant thing pursuant regulation 28(3)(i) may practicable-- (a) take multiple sample (b) place sample separate container (c) forthwith seal mark container manner identify part sample taken authorised officer (2) authorised officer sealed marked sample relevant thing accordance paragraph (1) shall-- (a) offer one sealed container owner person time charge possession relevant thing sample concerned taken (b) retain one sealed container (c) forward cause forwarded one sealed container test examination analysis sample concerned approved examiner appropriate examination authority (3) relevant thing contained container whatever reason practicable take multiple sample authorised officer wish take sample relevant thing purpose test examination analysis may take possession 3 container belonging batch lot container shall deemed part sample purpose paragraph (1) provision paragraph (1) (2) shall apply thereto accordingly 261 31 (4) authorised officer purchase take without payment relevant thing pursuant regulation 28(3)(j) may practicable-- (a) place relevant thing container (b) (c) forthwith seal mark container manner identify relevant thing taken pursuant subparagraph forward cause forwarded sealed container test examination analysis relevant thing approved examiner production order", "start_char": 67287, "end_char": 69337, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-30", "parent_doc_id": "si-2021-0261", "section_id": "reg-30", "section_label": "Regulation 30.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "30. (1) For the purpose of investigating compliance with the EU Regulation", "text_raw": "30. (1) For the purpose of investigating compliance with the EU Regulation \nand these Regulations, an authorised officer may apply to a judge of the District \nCourt for an order under this Regulation (“production order”) in relation to \nmaking available any particular material or material of a particular description. \n\n(2) On an application under paragraph (1), the judge, if satisfied— \n\n(a) \n\nthat there are reasonable grounds for suspecting that the person \non whom the order is to be served has the material concerned in \nhis or her possession or has access to such material, and \n\n(b) \n\nthat the material concerned is required for the purpose of such \ninvestigation, \n\nmay order that the person shall— \n\n(i) \n\n(ii) \n\nproduce the material to the authorised officer so that he or \nshe may take it away, or \n\ngive the authorised officer access to it within a period to be \nspecified in the order. \n\n(3) The period to be so specified shall be one week, unless it appears to the \njudge that another period would be appropriate in the particular circumstances \nof the case. \n\n(4) An order under this Regulation in relation to material in any place may, \non the application of the authorised officer concerned, require any person who \nappears to the judge to be entitled to grant entry to the place to allow the \nauthorised officer to enter it to obtain access to the material. \n\n(5) Where a person required under paragraph (4) to allow an authorised \nofficer to enter a place does not allow the authorised officer to do so, the person \nshall be treated as if he or she is in breach of a warrant issued under Regulation \n28(6) authorising him or her to search the place and any person found there. \n\n(6) Where material to which a production order relates consists of \ninformation stored electronically, the order shall have effect as an order to \nproduce the material, or to give access to it, in a form in which it is visible and \nlegible and in which it can be taken away. \n\n \n \n \n\f32 [261] \n\n(7) A production order — \n\n(a) \n\n(b) \n\n(c) \n\nin so far as it may empower an authorised officer to take away a \ndocument or to be given access to it, shall authorise him or her to \nmake a copy of it and to take the copy away, \n\nshall not confer any right to production of, or access to, any \nmaterial subject to legal privilege, and \n\nshall have effect notwithstanding any other obligation as to \nsecrecy or other restriction on disclosure of information imposed \nby statute or otherwise. \n\n(8) Any material taken away by an authorised officer under this Regulation \n\nmay be retained by him or her for use as evidence in any proceedings. \n\n(9) A judge of the District Court may vary or discharge an order under this \nRegulation on the application of any person to whom an order under this \nRegulation relates or an authorised officer. \n\nQuarantine notice", "text_norm": "30 (1) purpose investigating compliance eu regulation regulation authorised officer may apply judge district court order regulation ( production order ) relation making available particular material material particular description (2) application paragraph (1) judge satisfied-- (a) reasonable ground suspecting person order served material concerned possession access material (b) material concerned required purpose investigation may order person shall-- (i) (ii) produce material authorised officer may take away give authorised officer access within period specified order (3) period specified shall one week unless appears judge another period would appropriate particular circumstance case (4) order regulation relation material place may application authorised officer concerned require person appears judge entitled grant entry place allow authorised officer enter obtain access material (5) person required paragraph (4) allow authorised officer enter place allow authorised officer person shall treated breach warrant issued regulation 28(6) authorising search place person found there (6) material production order relates consists information stored electronically order shall effect order produce material give access form visible legible taken away 32 261 (7) production order -- (a) (b) (c) far may empower authorised officer take away document given access shall authorise make copy take copy away shall confer right production access material subject legal privilege shall effect notwithstanding obligation secrecy restriction disclosure information imposed statute otherwise (8) material taken away authorised officer regulation may retained use evidence proceeding (9) judge district court may vary discharge order regulation application person order regulation relates authorised officer quarantine notice", "start_char": 69337, "end_char": 72188, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-31", "parent_doc_id": "si-2021-0261", "section_id": "reg-31", "section_label": "Regulation 31.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "31. (1) Where an authorised officer, other than an authorised officer who is", "text_raw": "31. (1) Where an authorised officer, other than an authorised officer who is \n\nan officer of Customs and Excise, is of the opinion that— \n\n(a) \n\n(b) \n\nthere is a potential non-compliance with a requirement of the EU \nRegulation in relation to a device or relevant thing, or \n\na device or relevant thing has the potential to pose a serious risk \nto human health, \n\nthe authorised officer may, with the approval of the chief executive of the \nAuthority, or another officer of the Authority designated by the chief executive \nof the Authority for that purpose, serve, or arrange to have served, on the \nmanufacturer, authorised representative, distributor, health institution, economic \noperator, notified body or other person(s) concerned a notice (“quarantine \nnotice”) in accordance with paragraph (2). \n\n(2) A quarantine notice shall— \n\n(a) be signed by the authorised officer issuing it, or the officer \n\nconsulted in accordance with paragraph (1), \n\n(b) \n\nstate the reason why quarantine is being applied or provide a \njustification for the quarantine action, \n\n(c) \n\nspecify— \n\n(i) \n\nthe provision or provisions of the EU Regulation with \nwhich there is non-compliance and the matters giving rise \nto the non-compliance, or \n\n(ii) \n\nthe serious risk to human health posed by the device or \nrelevant thing, and \n\n(d) direct the person on whom the quarantine notice is served to \nensure that the device or relevant thing is not made available on \nthe market or put into service until all the necessary conditions \n\n \n \n\f[261] 33 \n\nfor the device or relevant thing to be compliant have been met or \nthe device or relevant thing no longer poses a serious risk to \nhuman health, as appropriate. \n\n(3) The approval referred to in paragraph (1) may be given orally or in \n\nwriting and if given orally shall be recorded in writing as soon as practicable. \n\n(4) Save in the case of a quarantine notice which takes effect immediately \nwhen it is received by the person on whom it is served, a quarantine notice shall \ngive the person on whom it is served a reasonable period within which he or she \nmay put forward his or her viewpoint on the notice or appeal the notice. \n\n(5) Where appropriate, the Authority shall, without delay, provide a copy of \nthe quarantine notice to the person(s) responsible for regulatory compliance of \nthe manufacturer or the authorised representative designated in respect of the \nrelevant device or relevant thing, and where necessary any importer(s) or \ndistributor(s). \n\n(6) Subject to paragraph (7)(a), a quarantine notice shall give the person on \nwhom it is served a reasonable period within which he or she may put forward \nhis or her viewpoint on the notice or appeal the notice. \n\n(7) A quarantine notice shall take effect— \n\n(a) where required, and where the quarantine notice so declares, \nimmediately when the notice is received by the person on whom \nit is served, or \n\n(b) \n\nin any other case— \n\n(i) where no appeal is taken against the quarantine notice, on \nexpiration of the period referred to in paragraph (6), or \n\n(ii) where an appeal is taken, on the day next following the day \non which the quarantine notice is confirmed on appeal or \nthe appeal is withdrawn or on the expiration of the period \nreferred to in paragraph (6), whichever is the later. \n\n(8) The chief executive of the Authority, or another officer of the Authority \ndesignated by the chief executive of the Authority for that purpose, may, for \nstated reasons, revoke or vary a quarantine notice issued by an authorised officer \nappointed by the Authority. \n\n(9) In the event of non-compliance by the person on whom a quarantine \nnotice has been served, an authorised officer, other than an authorised officer \nwho is an officer of Customs and Excise, shall, with the approval of the chief \nexecutive of the Authority, or another officer thereof designated by the chief \nexecutive of the Authority for that purpose, take whatever measures are \nconsidered necessary to ensure compliance with the quarantine notice, including \nthe seizure, detention and destruction of the device in question or the making of \nany arrangements for such seizure, detention and destruction. \n\n(10) This Regulation shall not operate to prevent or restrict— \n\n(a) \n\nthe entitlement of the Authority to take other action to secure \ncompliance with the EU legislation and these Regulations by a \nperson, or \n\n \n\f34 [261] \n\n(b) \n\nthe bringing or prosecuting of any proceedings for an offence \nunder these Regulations. \n\nCompliance notice", "text_norm": "31 (1) authorised officer authorised officer officer custom excise opinion that-- (a) (b) potential non-compliance requirement eu regulation relation device relevant thing device relevant thing potential pose serious risk human health authorised officer may approval chief executive authority another officer authority designated chief executive authority purpose serve arrange served manufacturer authorised representative distributor health institution economic operator notified body person(s) concerned notice ( quarantine notice ) accordance paragraph (2) (2) quarantine notice shall-- (a) signed authorised officer issuing officer consulted accordance paragraph (1) (b) state reason quarantine applied provide justification quarantine action (c) specify-- (i) provision provision eu regulation non-compliance matter giving rise non-compliance (ii) serious risk human health posed device relevant thing (d) direct person quarantine notice served ensure device relevant thing made available market put service necessary condition 261 33 device relevant thing compliant met device relevant thing longer pose serious risk human health appropriate (3) approval referred paragraph (1) may given orally writing given orally shall recorded writing soon practicable (4) save case quarantine notice take effect immediately received person served quarantine notice shall give person served reasonable period within may put forward viewpoint notice appeal notice (5) appropriate authority shall without delay provide copy quarantine notice person(s) responsible regulatory compliance manufacturer authorised representative designated respect relevant device relevant thing necessary importer(s) distributor(s) (6) subject paragraph (7)(a) quarantine notice shall give person served reasonable period within may put forward viewpoint notice appeal notice (7) quarantine notice shall take effect-- (a) required quarantine notice declares immediately notice received person served (b) case-- (i) appeal taken quarantine notice expiration period referred paragraph (6) (ii) appeal taken day next following day quarantine notice confirmed appeal appeal withdrawn expiration period referred paragraph (6) whichever later (8) chief executive authority another officer authority designated chief executive authority purpose may stated reason revoke vary quarantine notice issued authorised officer appointed authority (9) event non-compliance person quarantine notice served authorised officer authorised officer officer custom excise shall approval chief executive authority another officer thereof designated chief executive authority purpose take whatever measure considered necessary ensure compliance quarantine notice including seizure detention destruction device question making arrangement seizure detention destruction (10) regulation shall operate prevent restrict-- (a) entitlement authority take action secure compliance eu legislation regulation person 34 261 (b) bringing prosecuting proceeding offence regulation compliance notice", "start_char": 72188, "end_char": 76715, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-32", "parent_doc_id": "si-2021-0261", "section_id": "reg-32", "section_label": "Regulation 32.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "32. (1) Where an authorised officer, other than an authorised officer who is", "text_raw": "32. (1) Where an authorised officer, other than an authorised officer who is \nan officer of Customs and Excise, is of the opinion that there is non-compliance \nwith a requirement of the EU Regulation, the authorised officer may, following \nconsultation with another officer of the Authority designated by the chief \nexecutive of the Authority for that purpose, serve, or arrange to have served, on \nthe person concerned a notice (“compliance notice”) in accordance with \nparagraph (2). \n\n(2) A compliance notice shall— \n\n(a) be signed by the authorised officer issuing it, or the officer \n\nconsulted in accordance with paragraph (1), \n\n(b) \n\nidentify the requirement(s) of the EU Regulation with which there \nhas not been compliance, \n\n(c) \n\nidentify the corrective actions to be taken, \n\n(d) where appropriate, direct the person on whom the compliance \nnotice is served to inform, without delay, the manufacturer, \nauthorised representative, distributor(s) or importer(s) of the \ndevice concerned of the corrective actions to be taken, and \n\n(e) \n\ngive a time period, commensurate with the nature of the risk, \nwithin which the person on whom the compliance notice is served \nmust \nto \ntake \nsubparagraph (c). \n\nthe corrective actions \n\nidentified pursuant \n\n(3) Where appropriate, the authorised officer shall, without delay, provide a \ncopy of the compliance notice to the person(s) responsible for regulatory \ncompliance of the manufacturer or the authorised representative designated in \nrespect of the device concerned and where necessary any importer(s) or \ndistributor(s). \n\n(4) Subject to paragraph (5)(a), a compliance notice shall give the person on \nwhom it is served a reasonable period within which he or she may put forward \nhis or her viewpoint on the notice or appeal the notice. \n\n(5) A compliance notice shall take effect— \n\n(a) where required, and where the compliance notice so declares, \nimmediately when the notice is received by the person on whom \nit is served, or \n\n(b) \n\nin any other case— \n\n(i) \n\n(ii) \n\nwhere no appeal is taken, on expiration of the period \nreferred to in paragraph (4), or \n\nwhere an appeal is taken, on the next day following the day \non which the notice is confirmed on appeal or the appeal is \n\n \n \n\f[261] 35 \n\nwithdrawn or on the expiration of the period referred to in \nparagraph (4), whichever is the later. \n\n(6) The chief executive of the Authority or another officer of the Authority \ndesignated by the chief executive of the Authority for that purpose may, for \nstated reasons, revoke or vary a compliance notice issued by an authorised \nofficer appointed by the chief executive of the Authority. \n\n(7) In the event of non-compliance with a compliance notice by the person \non whom a compliance notice has been served, an authorised officer shall, with \nthe approval of the chief executive of the Authority, or another officer thereof \ndesignated by the chief executive of the Authority for that purpose, take \nwhatever measures are considered necessary to ensure compliance with the \ncompliance notice, including the seizure, detention and destruction of the \nrelevant thing or device in question or the making of any arrangements for such \nseizure, detention and destruction. \n\n(8) This Regulation shall not operate to prevent or restrict— \n\n(a) \n\nthe entitlement of the Authority to take other action to secure \ncompliance with the EU Regulation and these Regulations by a \nperson, or \n\n(b) \n\nthe bringing or prosecuting of any proceedings for an offence \nunder these Regulations. \n\nProhibition order", "text_norm": "32 (1) authorised officer authorised officer officer custom excise opinion non-compliance requirement eu regulation authorised officer may following consultation another officer authority designated chief executive authority purpose serve arrange served person concerned notice ( compliance notice ) accordance paragraph (2) (2) compliance notice shall-- (a) signed authorised officer issuing officer consulted accordance paragraph (1) (b) identify requirement(s) eu regulation compliance (c) identify corrective action taken (d) appropriate direct person compliance notice served inform without delay manufacturer authorised representative distributor(s) importer(s) device concerned corrective action taken (e) give time period commensurate nature risk within person compliance notice served must take subparagraph (c) corrective action identified pursuant (3) appropriate authorised officer shall without delay provide copy compliance notice person(s) responsible regulatory compliance manufacturer authorised representative designated respect device concerned necessary importer(s) distributor(s) (4) subject paragraph (5)(a) compliance notice shall give person served reasonable period within may put forward viewpoint notice appeal notice (5) compliance notice shall take effect-- (a) required compliance notice declares immediately notice received person served (b) case-- (i) (ii) appeal taken expiration period referred paragraph (4) appeal taken next day following day notice confirmed appeal appeal 261 35 withdrawn expiration period referred paragraph (4) whichever later (6) chief executive authority another officer authority designated chief executive authority purpose may stated reason revoke vary compliance notice issued authorised officer appointed chief executive authority (7) event non-compliance compliance notice person compliance notice served authorised officer shall approval chief executive authority another officer thereof designated chief executive authority purpose take whatever measure considered necessary ensure compliance compliance notice including seizure detention destruction relevant thing device question making arrangement seizure detention destruction (8) regulation shall operate prevent restrict-- (a) entitlement authority take action secure compliance eu regulation regulation person (b) bringing prosecuting proceeding offence regulation prohibition order", "start_char": 76715, "end_char": 80278, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-33", "parent_doc_id": "si-2021-0261", "section_id": "reg-33", "section_label": "Regulation 33.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "33. (1) Where the Authority is of the opinion that—", "text_raw": "33. (1) Where the Authority is of the opinion that— \n\n(a) \n\n(b) \n\nthere is non-compliance with a requirement of the EU Regulation, \n\na device presents an unacceptable risk to the health or safety of \npatients, users or other persons, or to other aspects of the \nprotection of public health, or \n\n(c) \n\na person has failed to comply with a compliance notice. \n\nthe Authority may serve, or arrange to have served, on the person concerned an \norder (“prohibition order”) in accordance with paragraph (2). \n\n(2) A prohibition order shall— \n\n(a) be signed by the chief executive officer of the authority or another \nofficer thereof authorised for that purpose by the chief executive \nofficer, \n\n(b) \n\n(c) \n\nstate that the Authority is of the opinion that a particular \nconsignment, group, category, batch or lot of the device \nconcerned is not in conformity with the EU Regulation, \n\nspecify the provision or provisions of the EU Regulation with \nwhich the device is not in compliance and the matters giving rise \nto the non-compliance, \n\n(d) where relevant, identify the part or parts of the compliance notice \n\nwith which there has not been compliance, and \n\n \n \n\f36 [261] \n\n(e) \n\ndirect the person on whom the prohibition order is served to \nensure that— \n\n(i) \n\n(ii) \n\n(iii) \n\n(iv) \n\n(v) \n\nthe device is not to be placed on the market, made available \non the market or put into service until such time as all \nappropriate measures, including corrective measures, have \nbeen taken to bring the device into conformity with the EU \nRegulation, \n\nthe placing on the market, making available on the market \nor putting into service of the device is restricted or made \nsubject to particular requirements, \n\nthe device is prohibited from being placed on the market, \nmade available on the market or put into service \n\nthe device is withdrawn or recalled from the market within \na specified time-limit, or \n\nthe device is destroyed within a specific time limit and in a \nmanner prescribed by the Authority or is detained for the \npurposes of destruction by an authorised officer. \n\n(3) The approval referred to in paragraph (1) may be given orally or in \n\nwriting and if given orally shall be recorded in writing as soon as practicable. \n\n(4) Where appropriate, the Authority shall, without delay, provide a copy of \nthe prohibition order to the person(s) responsible for regulatory compliance of \nthe manufacturer/authorised representative designated in respect of the device \nconcerned, and where necessary any importer(s) or distributor(s). \n\n(5) A prohibition order shall take effect— \n\n(a) where the prohibition order so declares, immediately the order is \n\nreceived by the person on whom it is served, or \n\n(b) \n\nin any other case— \n\n(i) where no appeal is taken against the prohibition order, on \nthe expiration of the period during which such an appeal \nmay be taken or the day specified in the prohibition order \nas the day on which it is to come into effect, whichever is \nthe later, or \n\n(ii) where an appeal is taken, on the day next following the day \non which the prohibition order is confirmed on appeal or \nthe appeal is withdrawn or the day specified in the \nprohibition order as the day on which it is to come into \neffect, whichever is the later. \n\n(6) The bringing of an appeal against a prohibition order which is to take \neffect in accordance with paragraph (5)(a) shall not have the effect of suspending \nthe operation of the prohibition order, but the appellant may apply to the Circuit \nCourt to have the operation of the prohibition order suspended until the appeal \nis disposed of and, on such application, the Circuit Court may, if it thinks it \nproper to do so, direct that the operation of the prohibition order be suspended \nuntil the appeal is disposed of. \n\n \n\f[261] 37 \n\n(7) In the event of non-compliance by the person on whom the prohibition \norder has been served, an authorised officer shall, with the approval of the chief \nexecutive of the Authority or other officer designated in that behalf by the chief \nexecutive of the Authority, take whatever steps are considered necessary to \nensure compliance with the direction given under paragraph (2)(e) and this may \ninclude the seizure, detention and destruction of the devices in question or the \nmaking of any arrangements for such seizure, detention and destruction. \n\n(8) This Regulation shall not operate to prevent or restrict— \n\n(a) \n\nthe entitlement of the Authority to take other action to secure \ncompliance with the EU legislation and these Regulations by a \nperson, or \n\n(b) \n\nthe bringing or prosecuting of any proceedings for an offence \nunder these Regulations. \n\n(9) The chief executive of the Authority may, for stated reasons, revoke or \nvary a prohibition order made in accordance with this Regulation and the \nAuthority shall be notified at the next available meeting of the Authority of any \nsuch revocation or variation and the reasons therefore. \n\n(10) Where a prohibition order has been served and activities are carried on \nin contravention of the prohibition order, the High Court may, on the application \nof the Authority, by order prohibit the continuance of the activities. \n\n(11) An application to the High Court for an order under paragraph (10) shall \nbe by motion and the Court, when considering the matter, may make such interim \nor interlocutory order (if any) as it considers appropriate and the order by which \nan application under paragraph (10) is determined may contain such terms and \nconditions (if any) as to the payment of costs as the Court considers appropriate. \n\nAppeals from quarantine notices and compliance notices", "text_norm": "33 (1) authority opinion that-- (a) (b) non-compliance requirement eu regulation device present unacceptable risk health safety patient user person aspect protection public health (c) person failed comply compliance notice authority may serve arrange served person concerned order ( prohibition order ) accordance paragraph (2) (2) prohibition order shall-- (a) signed chief executive officer authority another officer thereof authorised purpose chief executive officer (b) (c) state authority opinion particular consignment group category batch lot device concerned conformity eu regulation specify provision provision eu regulation device compliance matter giving rise non-compliance (d) relevant identify part part compliance notice compliance 36 261 (e) direct person prohibition order served ensure that-- (i) (ii) (iii) (iv) (v) device placed market made available market put service time appropriate measure including corrective measure taken bring device conformity eu regulation placing market making available market putting service device restricted made subject particular requirement device prohibited placed market made available market put service device withdrawn recalled market within specified time-limit device destroyed within specific time limit manner prescribed authority detained purpose destruction authorised officer (3) approval referred paragraph (1) may given orally writing given orally shall recorded writing soon practicable (4) appropriate authority shall without delay provide copy prohibition order person(s) responsible regulatory compliance manufacturer authorised representative designated respect device concerned necessary importer(s) distributor(s) (5) prohibition order shall take effect-- (a) prohibition order declares immediately order received person served (b) case-- (i) appeal taken prohibition order expiration period appeal may taken day specified prohibition order day come effect whichever later (ii) appeal taken day next following day prohibition order confirmed appeal appeal withdrawn day specified prohibition order day come effect whichever later (6) bringing appeal prohibition order take effect accordance paragraph (5)(a) shall effect suspending operation prohibition order appellant may apply circuit court operation prohibition order suspended appeal disposed application circuit court may think proper direct operation prohibition order suspended appeal disposed of 261 37 (7) event non-compliance person prohibition order served authorised officer shall approval chief executive authority officer designated behalf chief executive authority take whatever step considered necessary ensure compliance direction given paragraph (2)(e) may include seizure detention destruction device question making arrangement seizure detention destruction (8) regulation shall operate prevent restrict-- (a) entitlement authority take action secure compliance eu legislation regulation person (b) bringing prosecuting proceeding offence regulation (9) chief executive authority may stated reason revoke vary prohibition order made accordance regulation authority shall notified next available meeting authority revocation variation reason therefore (10) prohibition order served activity carried contravention prohibition order high court may application authority order prohibit continuance activity (11) application high court order paragraph (10) shall motion court considering matter may make interim interlocutory order (if any) considers appropriate order application paragraph (10) determined may contain term condition (if any) payment cost court considers appropriate appeal quarantine notice compliance notice", "start_char": 80278, "end_char": 85925, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-34", "parent_doc_id": "si-2021-0261", "section_id": "reg-34", "section_label": "Regulation 34.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "34. (1) A person may appeal a quarantine notice or compliance notice", "text_raw": "34. (1) A person may appeal a quarantine notice or compliance notice \nserved on him or her in accordance with appeals procedures provided in \nguidelines published by the Authority. \n\n(2) The Authority shall inform a person of his or her right of appeal, and the \napplicable time limits, when serving him or her with a quarantine notice or \ncompliance notice. \n\n(3) A person who is aggrieved by a decision on an appeal under paragraph \n(1) may appeal that decision to the District Court in the district court district in \nwhich the quarantine notice or compliance notice was served, not later than 7 \ndays after the decision concerned. \n\n(4) The bringing of an appeal under this Regulation against a notice which \nis to take effect immediately on service shall not have the effect of suspending \nthe operation of the notice, but the appellant may apply— \n\n(a) \n\nin the case of an appeal under paragraph (1), in accordance with \nthe procedures referred to therein, or \n\n(b) \n\nin the case of an appeal under paragraph (3), to the District Court, \n\n \n \n\f38 [261] \n\nto have the operation of the quarantine notice or compliance notice concerned \nsuspended until the appeal is disposed of. \n\n(5) The District Court shall, upon an appeal under paragraph (3), do one of \n\nthe following: \n\n(a) \n\naffirm the notice concerned; \n\n(b) direct the Authority to withdraw the notice concerned; or \n\n(c) \n\ndirect the Authority to modify the notice concerned. \n\n(6) The Authority shall comply with a direction under paragraph (5)(b) or \n\n(c). \n\n(7) Where on the hearing of an appeal under paragraph (3) a notice is \naffirmed, notwithstanding Regulation 31(7) or 32(5), as applicable, the judge of \nthe District Court by whom the appeal is heard may, on the application of the \nappellant, suspend the operation of the notice for such period as in the \ncircumstances of the case the district judge considers appropriate. \n\n(8) A person who appeals under paragraph (3) or who applies for a direction \nunder paragraph (7) shall at the same time notify the Authority of the appeal or \napplication and the grounds for the appeal or application and the Authority shall \nbe entitled to appear, be heard and adduce evidence on the hearing of the appeal \nor application. \n\n(9) A decision of the District Court on an appeal under paragraph (3) shall \n\nbe final. \n\nAppeals from prohibition orders", "text_norm": "34 (1) person may appeal quarantine notice compliance notice served accordance appeal procedure provided guideline published authority (2) authority shall inform person right appeal applicable time limit serving quarantine notice compliance notice (3) person aggrieved decision appeal paragraph (1) may appeal decision district court district court district quarantine notice compliance notice served later 7 day decision concerned (4) bringing appeal regulation notice take effect immediately service shall effect suspending operation notice appellant may apply-- (a) case appeal paragraph (1) accordance procedure referred therein (b) case appeal paragraph (3) district court 38 261 operation quarantine notice compliance notice concerned suspended appeal disposed of (5) district court shall upon appeal paragraph (3) one following (a) affirm notice concerned (b) direct authority withdraw notice concerned (c) direct authority modify notice concerned (6) authority shall comply direction paragraph (5)(b) (c) (7) hearing appeal paragraph (3) notice affirmed notwithstanding regulation 31(7) 32(5) applicable judge district court appeal heard may application appellant suspend operation notice period circumstance case district judge considers appropriate (8) person appeal paragraph (3) applies direction paragraph (7) shall time notify authority appeal application ground appeal application authority shall entitled appear heard adduce evidence hearing appeal application (9) decision district court appeal paragraph (3) shall final appeal prohibition order", "start_char": 85925, "end_char": 88292, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-35", "parent_doc_id": "si-2021-0261", "section_id": "reg-35", "section_label": "Regulation 35.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "35. (1) A person may appeal a prohibition order served on him or her, to the", "text_raw": "35. (1) A person may appeal a prohibition order served on him or her, to the \nCircuit Court in the circuit in which the order was served, not later than 7 days \nafter the service of the notice or order concerned. \n\n(2) The bringing of an appeal under this Regulation against a prohibition \nwhich is to take effect immediately on service shall not have the effect of \nsuspending the operation of the order, but the appellant may apply to the Circuit \nCourt to have the operation of the order suspended until the appeal is disposed \nof and, on such application, the Court may, if it thinks it proper to do so, direct \nthat the operation of the order be suspended until the appeal is disposed of. \n\n(3) The Circuit Court shall, upon an appeal under this Regulation, do one of \n\nthe following: \n\n(a) \n\naffirm the order concerned; \n\n(b) direct the Authority to withdraw the order concerned; or \n\n(c) \n\ndirect the Authority to modify the order concerned. \n\n(4) The Authority shall comply with a direction under paragraph (3)(b) or \n\n(c). \n\n(5) Where on the hearing of an appeal under this Regulation an order is \naffirmed, notwithstanding paragraph (5) of Regulation 33, as applicable, the \njudge of the Circuit Court by whom the appeal is heard may, on the application \n\n \n \n\f[261] 39 \n\nof the appellant, suspend the operation of the order for such period as in the \ncircumstances of the case the judge considers appropriate. \n\n(6) A person who appeals under this Regulation or who applies for a \ndirection under paragraph (5) shall at the same time notify the Authority of the \nappeal or application and the grounds for the appeal or application and the \nAuthority shall be entitled to appear, be heard and adduce evidence on the \nhearing of the appeal or application. \n\n(7) A decision of the Circuit Court on an appeal under this Regulation shall \nbe final, save that, by leave of the Court an appeal from the decision shall lie to \nthe High Court on a specified question of law. \n\nDestruction and disposal", "text_norm": "35 (1) person may appeal prohibition order served circuit court circuit order served later 7 day service notice order concerned (2) bringing appeal regulation prohibition take effect immediately service shall effect suspending operation order appellant may apply circuit court operation order suspended appeal disposed application court may think proper direct operation order suspended appeal disposed of (3) circuit court shall upon appeal regulation one following (a) affirm order concerned (b) direct authority withdraw order concerned (c) direct authority modify order concerned (4) authority shall comply direction paragraph (3)(b) (c) (5) hearing appeal regulation order affirmed notwithstanding paragraph (5) regulation 33 applicable judge circuit court appeal heard may application 261 39 appellant suspend operation order period circumstance case judge considers appropriate (6) person appeal regulation applies direction paragraph (5) shall time notify authority appeal application ground appeal application authority shall entitled appear heard adduce evidence hearing appeal application (7) decision circuit court appeal regulation shall final save leave court appeal decision shall lie high court specified question law destruction disposal", "start_char": 88292, "end_char": 90298, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-36", "parent_doc_id": "si-2021-0261", "section_id": "reg-36", "section_label": "Regulation 36.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "36. Where—", "text_raw": "36. Where— \n\n(a) \n\nany relevant thing, book, record, document, or premises is \ndetained under this Part, but is not the subject of a prosecution, \nand \n\n(i) \n\nno claim is made for its return within 28 days of notice in \nwriting being given of the intention to destroy or dispose of \nsame, or render same inoperable, or \n\n(ii) \n\nthe supplier of the relevant thing is not reasonably \nidentifiable, or \n\n(b) \n\na device being supplied at a distance by information society \nservices in contravention of the EU Regulation is detained, \n\nan authorised officer may destroy or dispose of, or render inoperable, such thing, \nbook, record, document, premises or device, in the interest of the protection of \npublic health. \n\nSuspension, restriction and withdrawal of designation of notified bodies", "text_norm": "36 where-- (a) relevant thing book record document premise detained part subject prosecution (i) claim made return within 28 day notice writing given intention destroy dispose render inoperable (ii) supplier relevant thing reasonably identifiable (b) device supplied distance information society service contravention eu regulation detained authorised officer may destroy dispose render inoperable thing book record document premise device interest protection public health suspension restriction withdrawal designation notified body", "start_char": 90298, "end_char": 91087, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-37", "parent_doc_id": "si-2021-0261", "section_id": "reg-37", "section_label": "Regulation 37.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "37. Where the Authority has ascertained that a notified body—", "text_raw": "37. Where the Authority has ascertained that a notified body— \n\n(a) no longer meets the applicable requirements set out in the EU \n\nRegulation, \n\n(b) \n\nis failing to fulfil its obligations, or \n\n(c) \n\nhas not implemented necessary corrective measures, \n\nthe Authority shall suspend, restrict or fully or partially withdraw the notified \nbody’s designation, in accordance with Article 46(4) of the EU Regulation. \n\nService of notices and orders", "text_norm": "37 authority ascertained notified body-- (a) longer meet applicable requirement set eu regulation (b) failing fulfil obligation (c) implemented necessary corrective measure authority shall suspend restrict fully partially withdraw notified body designation accordance article 46(4) eu regulation service notice order", "start_char": 91087, "end_char": 91533, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-38", "parent_doc_id": "si-2021-0261", "section_id": "reg-38", "section_label": "Regulation 38.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "38. (1) A notice or order served or given by or under this Part shall be", "text_raw": "38. (1) A notice or order served or given by or under this Part shall be \naddressed to the person concerned and served or given in one of the following \nmanners: \n\n \n \n \n \n\f40 [261] \n\n(a) by addressing it to the person by name and delivering it to him or \n\nher; \n\n(b) by leaving it at the address at which the person ordinarily resides \n\nor carries on business; \n\n(c) \n\n(d) \n\nby sending it by post in a prepaid registered letter addressed to the \nperson at the address at which he or she ordinarily resides or \ncarries on business; \n\nif an address for the service of notices has been furnished by the \nperson, by leaving it at, or sending it by prepaid registered post \naddressed to him or her to, that address; \n\n(e) where the address at which the person ordinarily resides or carries \non business cannot be ascertained by reasonable inquiry and \nnotice is required to be served on, or given to, him or her in \nrespect of any premises by delivering it to a person over the age \nof 16 years resident in or employed on the premises, or by affixing \nit in a conspicuous position on or near the premises; or \n\n(f) \n\nby sending it by means of electronic mail to a device or facility \nfor the reception of electronic mail where such an electronic mail \naddress has been furnished by the person, but only if the sender’s \nfacility for the reception of electronic mail generates a message \nconfirming a receipt of the electronic mail confirming successful \ntransmission of the notice. \n\n(2) Where the name of the person concerned cannot be ascertained by \nreasonable inquiry, a notice or order under this Part may be addressed to “the \noccupier”, “the owner” or “the person in charge”, as the case may be. \n\n(3) For the purposes of this Regulation, a company within the meaning of \nthe Companies Act 2014 (No. 38 of 2014) shall be deemed to be ordinarily \nresident at its registered office, and every other body corporate and every \nunincorporated body shall be deemed to be ordinarily resident at its principal \noffice or place of business. \n\n(4) A person shall not at any time during the period of 3 months after a notice \nis affixed under paragraph (1)(e) remove, damage or deface the notice without \nlawful authority. \n\nPART 5 \n\nREVOCATIONS AND TRANSITIONAL PROVISIONS \n\nRevocations", "text_norm": "38 (1) notice order served given part shall addressed person concerned served given one following manner 40 261 (a) addressing person name delivering (b) leaving address person ordinarily resides carry business (c) (d) sending post prepaid registered letter addressed person address ordinarily resides carry business address service notice furnished person leaving sending prepaid registered post addressed address (e) address person ordinarily resides carry business cannot ascertained reasonable inquiry notice required served given respect premise delivering person age 16 year resident employed premise affixing conspicuous position near premise (f) sending mean electronic mail device facility reception electronic mail electronic mail address furnished person sender facility reception electronic mail generates message confirming receipt electronic mail confirming successful transmission notice (2) name person concerned cannot ascertained reasonable inquiry notice order part may addressed occupier owner person charge case may be (3) purpose regulation company within meaning company act 2014 (no 38 2014) shall deemed ordinarily resident registered office every body corporate every unincorporated body shall deemed ordinarily resident principal office place business (4) person shall time period 3 month notice affixed paragraph (1)(e) remove damage deface notice without lawful authority part 5 revocation transitional provision revocation", "start_char": 91533, "end_char": 93815, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-39", "parent_doc_id": "si-2021-0261", "section_id": "reg-39", "section_label": "Regulation 39.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "39. The following are revoked:", "text_raw": "39. The following are revoked: \n\n(a) \n\n(b) \n\nthe Regulations of 1994; \n\nthe European Communities (Active Implantable Medical \nDevices) Regulations 1994 (S.I. No. 253 of 1994); \n\n \n \n \n \n\f[261] 41 \n\n(c) \n\n(d) \n\n(e) \n\n(f) \n\n(g) \n\n(h) \n\n(i) \n\n(j) \n\n(k) \n\n(l) \n\nthe European Communities (Medical Devices) (Amendment) \nRegulations 2001 (S.I. No. 444 of 2001); \n\nthe European Communities (Medical Devices) (Amendment) \nRegulations 2002 (S.I. No. 576 of 2002), other than Regulation 3 \nthereof; \n\nthe European Communities (Medical Devices) (Tissues of \nAnimal Origin) Regulations 2003 (S.I. No. 554 of 2003); \n\nthe European Communities (Medical Devices) (Reclassification \nof Breast Implants) (Amendment) Regulations 2003 (S.I. No. 358 \nof 2003); \n\nthe European Communities (Medical Devices) (Reclassification \nof Hip, Knee and Shoulder Joint Replacements) (Amendment) \nRegulations 2007 (S.I. No. 92 of 2007); \n\nthe European Communities (Active Implantable Medical \nDevices) (Amendment) Regulations 2009 (S.I. No. 109 of 2009); \n\nthe European Communities (Medical Devices) (Amendment) \nRegulations 2009 (S.I. No. 110 of 2009); \n\nthe European Communities (Medical Devices) (Amendment) \nRegulations 2020 (S.I. No. 144 of 2020); \n\nthe European Communities (Active Implantable Medical \nDevices) (Amendment) Regulations 2020 (S.I. No. 300 of 2020); \n\nthe European Communities (Medical Devices) (Amendment) \n(No. 2) Regulations 2020 (S.I. No. 301 of 2020). \n\nTransitional provisions", "text_norm": "39 following revoked (a) (b) regulation 1994 european community (active implantable medical devices) regulation 1994 (s.i no 253 1994) 261 41 (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) european community (medical devices) (amendment) regulation 2001 (s.i no 444 2001) european community (medical devices) (amendment) regulation 2002 (s.i no 576 2002) regulation 3 thereof european community (medical devices) (tissues animal origin) regulation 2003 (s.i no 554 2003) european community (medical devices) (reclassification breast implants) (amendment) regulation 2003 (s.i no 358 2003) european community (medical devices) (reclassification hip knee shoulder joint replacements) (amendment) regulation 2007 (s.i no 92 2007) european community (active implantable medical devices) (amendment) regulation 2009 (s.i no 109 2009) european community (medical devices) (amendment) regulation 2009 (s.i no 110 2009) european community (medical devices) (amendment) regulation 2020 (s.i no 144 2020) european community (active implantable medical devices) (amendment) regulation 2020 (s.i no 300 2020) european community (medical devices) (amendment) (no 2) regulation 2020 (s.i no 301 2020) transitional provision", "start_char": 93815, "end_char": 95287, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-reg-40", "parent_doc_id": "si-2021-0261", "section_id": "reg-40", "section_label": "Regulation 40.", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "40. (1) Notwithstanding the provisions of these Regulations—", "text_raw": "40. (1) Notwithstanding the provisions of these Regulations— \n\n(a) \n\na person is not guilty of an offence by reason of relying upon a \ncertificate issued by a notified body in accordance with Directives \n90/385/EEC and 93/42/EEC (other than Annex 4 to Directive \n90/385/EEC or Annex IV to Directive 93/42/EEC) prior to 25 \nMay 2017 provided that the period indicated on the certificate has \nnot expired, \n\n(b) until 27 May 2022, a person is not guilty of an offence by reason \nof relying upon a certificate issued by a notified body in \naccordance with Annex 4 to Directive 90/385/EEC or Annex IV \nto Directive 93/42/EEC prior to 25 May 2017 provided that the \nperiod indicated on the certificate has not expired, \n\n(c) \n\nuntil 27 May 2024, a person is not guilty of an offence by reason \nof relying upon a certificate issued by a notified body in \naccordance with Directives 90/385/EEC and 93/42/EEC on or \nafter 25 May 2017, provided that the period indicated on the \ncertificate has not expired and less than five years have passed \nsince its issuance, \n\n \n \n\f42 [261] \n\n(d) \n\n(e) \n\n(f) \n\n(g) \n\na person is not guilty of an offence by reason of placing on the \nmarket or putting into service, on or before 26 May 2024, a device \nwhich is a class I device pursuant to Directive 93/42/EEC, for \nwhich the declaration of conformity was drawn up prior to 26 \nMay 2021 and for which the conformity assessment procedure \npursuant to the EU Regulation requires the involvement of a \nnotified body, or which has a certificate that was issued in \naccordance with Directive 90/385/EEC or Directive 93/42/EEC \nand that is valid by virtue of Article 120(2) of the EU Regulation, \nprovided that— \n\n(i) \n\n(ii) \n\n(iii) \n\nfrom 26 May 2021 the device continues to comply with \neither of those Directives, \n\nthere are no significant changes in the design and intended \npurpose of the device, and \n\nthe requirements of the EU Regulation relating to postmarket surveillance, market surveillance, vigilance, \nregistration of economic operators and of devices are \ncomplied with in place of the corresponding requirements \nin those Directives, \n\nuntil 26 May 2025, a person is not guilty of an offence by reason \nof making available on the market or putting into service a device \nlawfully placed on the market pursuant to Directives 90/385/EEC \nand 93/42/EEC prior to 26 May 2021, or a device placed on the \nmarket from 26 May 2021 pursuant to Article 120(3) of the EU \nRegulation, \n\na person is not guilty of an offence by reason of placing on the \nmarket or putting into service a device manufactured utilising \nderivatives of tissues or cells of human origin which are nonviable or are rendered non-viable, which device has been legally \nplaced on the market or put into service in accordance with the \nrules in force in the State prior to 26 May 2021, \n\na sponsor is not guilty of an offence by reason of the continuance \nof a clinical investigation which was started in accordance with \nArticle 10 of Directive 90/335/EEC or Article 15 of Directive \n93/42/EEC before 26 May 2021, provided that the reporting of \nserious adverse events and device deficiencies is carried out in \naccordance with the EU Regulation. \n\n(2) Notwithstanding Regulation 39, until the Eudamed functionality date— \n\n(a) \n\nthe manufacturer’s undertaking in— \n\n(i) \n\nthe seventh indent under paragraph 3.1 of Schedule 2, \n\n(ii) paragraph 3 of Schedule 4, \n\n(iii) \n\nthe eighth indent under paragraph 3.1 of Schedule 5, \n\n(iv) \n\nthe eighth indent under paragraph 3.1 of Schedule 6, and \n\n(v) paragraphs 4 and 5 of Schedule 7, \n\n \n\f[261] 43 \n\nto the Regulations of 1994 (as amended by Regulation 29 of the \nEuropean Communities \n(Amendment) \nRegulations 2009), \n\n(Medical Devices) \n\n(b) Article 28 (inserted by Regulation 4 of \n\nCommunities \nRegulations 2020) of the Regulations of 1994, \n\n(Medical Devices) \n\n(Amendment) \n\nthe European \n(No. 2) \n\n(c) \n\nthe manufacturer’s undertaking in— \n\n(i) \n\nthe fifth indent under paragraph 3.1 of Schedule 2, \n\n(ii) paragraph 4 of Schedule 4, \n\n(iii) \n\nthe sixth indent under paragraph 3.1 of Schedule 5, and \n\n(iv) paragraph 5 of Schedule 6, \n\nto the European Communities (Active Implantable Medical \nDevices) Regulations 1994 (as amended by Regulation 17 of the \nEuropean Communities (Active Implantable Medical Devices) \n(Amendment) Regulations 2009), \n\n(d) Article 22 (inserted by Regulation 4 of \n(Active \n\nthe European \nCommunities \nImplantable Medical Devices) \n(Amendment) Regulations 2020) of the European Communities \n(Active Implantable Medical Devices) Regulations 1994 \n\n(e) Articles 4(8) and 10, Schedule 6, paragraphs 1, 2.2 and 3.2 and \nSchedule 7 (as amended by Regulations 14 and 17 of the \nEuropean Communities (Active Implantable Medical Devices) \n(Amendment) Regulations 2009) of the European Communities \n(Active Implantable Medical Devices) Regulations 1994 in \nrelation to notification procedures and the provision and \nexchange of documentation regarding clinical investigations \n\n(f) Articles 5(8) and 16 and Schedules 8 and 10 (as amended by \nRegulations 26 and 29 of the European Communities (Medical \nDevices) (Amendment) Regulations 2009) of the Regulations of \n1994, \n\ncontinue to apply as if they had not been revoked, for the purposes of information \nand data exchange only, and a person who fails to comply with same is guilty of \nan offence. \n\n(3) Notwithstanding Regulation 39— \n\n(a) Article 17 (as amended by Regulation 9 of the European \nCommunities (Medical Devices) (Amendment) Regulations \n2001) of the Regulations of 1994, and \n\n(b) Article 11 (as amended by Regulation 15 of the European \nCommunities \nImplantable Medical Devices) \n(Amendment) Regulations 2009) of the European Communities \n(Active Implantable Medical Devices) Regulations 1994, \n\n(Active \n\ncontinue to apply, as if they had not been revoked, in respect of— \n\n \n\f44 [261] \n\n(i) \n\n(ii) \n\ndevices granted CE Marking approval thereunder and made \navailable on the market or put into service up to 27 May \n2025, and \n\nthe means by which information is to be exchanged with \nand notifications to the Authority until Eudamed is \nfunctional. \n\n(4) Notwithstanding Regulation 39, as regards the devices referred to in \nparagraph (1)(d) and (e), the Regulations of 1994 and the European \nCommunities (Active Implantable Medical Devices) Regulations 1994, as \namended, continue to apply until 27 May 2025 to the extent necessary for the \napplication of Articles 120(3) and (4) of the EU Regulation, as if those \nRegulations had not been revoked. \n\n(5) For the purposes of paragraphs (1) to (4), notwithstanding Regulation 39, \nRegulation 2 of the European Communities (Medical Devices) (Amendment) \nRegulations 2001 and the enforcement provisions of the Regulations of 1994 and \nthe European Communities (Active Implantable Medical Devices) Regulations \n1994, as amended, continue to apply, as if they had not been revoked, for the \nperiods referred to in those paragraphs. \n\n(6) Notwithstanding the provisions of these Regulations, until 6 months after \n\nthe Eudamed functionality date, the offences in— \n\n(a) Regulation 16(1)(z), (aa), (bb), and (ll), \n\n(b) Regulation 17(e) and (f), \n\n(c) Regulation 19(j) and (k), \n\n(d) Regulation 20(c) and (d) \n\n(e) Regulation 21(p), and \n\n(f) Regulation 25(o), \n\ndo not apply, in so far as they apply to using Eudamed as the mechanism for \ninformation exchange. \n\n(7) Notwithstanding the provisions of these Regulations, until 18 months \n\nafter the Eudamed functionality date, the offences in— \n\n(a) Regulation 16(1)(cc) and (dd), and \n\n(b) Regulation 21(r), \n\ndo not apply. \n\n(8) Notwithstanding the provisions of these Regulations— \n\n(a) until 26 May 2023, for class IIa and class IIb devices, and \n\n(b) until 26 May 2025, for class I devices, \n\nthe offence in Regulations 16(1)(x) does not apply. \n\n(9) Notwithstanding the provisions of these Regulations, with regard to \nreusable devices that are required to bear the UDI carrier on the device itself— \n\n(a) until 26 May 2023, for implantable devices and class III devices, \n\n(b) until 26 May 2025, for class IIa and class IIb devices, and \n\n \n\f[261] 45 \n\n(c) \n\nuntil 26 May 2027, for class I devices, \n\nthe offence in Regulation 16(1)(x) does not apply. \n\n(10) In this Regulation— \n\n“Directive 90/385/EEC” means Council Directive 90/385/EEC of 20 June \n19908; \n“Directive 93/42/EEC” means Council Directive 93/42/EEC of 14 June 19939; \n\n“Eudamed functionality date” means the date of publication of the notice \nreferred to in Article 24(3) of the EU Regulation. \n\n8 OJ No. L 189, 20.7.1990, p. 17. \n9 OJ No. L 169, 12.7.1993, p. 1. \n\n \n \n \n \n\f46 [261] \n\nGIVEN under my Official Seal, \n\n25 May, 2021. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n\f[261] 47", "text_norm": "40 (1) notwithstanding provision regulations-- (a) person guilty offence reason relying upon certificate issued notified body accordance directive 90 385 eec 93 42 eec (other annex 4 directive 90 385 eec annex iv directive 93 42 eec) prior 25 may 2017 provided period indicated certificate expired (b) 27 may 2022 person guilty offence reason relying upon certificate issued notified body accordance annex 4 directive 90 385 eec annex iv directive 93 42 eec prior 25 may 2017 provided period indicated certificate expired (c) 27 may 2024 person guilty offence reason relying upon certificate issued notified body accordance directive 90 385 eec 93 42 eec 25 may 2017 provided period indicated certificate expired le five year passed since issuance 42 261 (d) (e) (f) (g) person guilty offence reason placing market putting service 26 may 2024 device class device pursuant directive 93 42 eec declaration conformity drawn prior 26 may 2021 conformity assessment procedure pursuant eu regulation requires involvement notified body certificate issued accordance directive 90 385 eec directive 93 42 eec valid virtue article 120(2) eu regulation provided that-- (i) (ii) (iii) 26 may 2021 device continues comply either directive significant change design intended purpose device requirement eu regulation relating postmarket surveillance market surveillance vigilance registration economic operator device complied place corresponding requirement directive 26 may 2025 person guilty offence reason making available market putting service device lawfully placed market pursuant directive 90 385 eec 93 42 eec prior 26 may 2021 device placed market 26 may 2021 pursuant article 120(3) eu regulation person guilty offence reason placing market putting service device manufactured utilising derivative tissue cell human origin nonviable rendered non-viable device legally placed market put service accordance rule force state prior 26 may 2021 sponsor guilty offence reason continuance clinical investigation started accordance article 10 directive 90 335 eec article 15 directive 93 42 eec 26 may 2021 provided reporting serious adverse event device deficiency carried accordance eu regulation (2) notwithstanding regulation 39 eudamed functionality date-- (a) manufacturer undertaking in-- (i) seventh indent paragraph 3.1 schedule 2 (ii) paragraph 3 schedule 4 (iii) eighth indent paragraph 3.1 schedule 5 (iv) eighth indent paragraph 3.1 schedule 6 (v) paragraph 4 5 schedule 7 261 43 regulation 1994 (as amended regulation 29 european community (amendment) regulation 2009) (medical devices) (b) article 28 (inserted regulation 4 community regulation 2020) regulation 1994 (medical devices) (amendment) european (no 2) (c) manufacturer undertaking in-- (i) fifth indent paragraph 3.1 schedule 2 (ii) paragraph 4 schedule 4 (iii) sixth indent paragraph 3.1 schedule 5 (iv) paragraph 5 schedule 6 european community (active implantable medical devices) regulation 1994 (as amended regulation 17 european community (active implantable medical devices) (amendment) regulation 2009) (d) article 22 (inserted regulation 4 (active european community implantable medical devices) (amendment) regulation 2020) european community (active implantable medical devices) regulation 1994 (e) article 4(8) 10 schedule 6 paragraph 1 2.2 3.2 schedule 7 (as amended regulation 14 17 european community (active implantable medical devices) (amendment) regulation 2009) european community (active implantable medical devices) regulation 1994 relation notification procedure provision exchange documentation regarding clinical investigation (f) article 5(8) 16 schedule 8 10 (as amended regulation 26 29 european community (medical devices) (amendment) regulation 2009) regulation 1994 continue apply revoked purpose information data exchange person fails comply guilty offence (3) notwithstanding regulation 39-- (a) article 17 (as amended regulation 9 european community (medical devices) (amendment) regulation 2001) regulation 1994 (b) article 11 (as amended regulation 15 european community implantable medical devices) (amendment) regulation 2009) european community (active implantable medical devices) regulation 1994 (active continue apply revoked respect of-- 44 261 (i) (ii) device granted ce marking approval thereunder made available market put service 27 may 2025 mean information exchanged notification authority eudamed functional (4) notwithstanding regulation 39 regard device referred paragraph (1)(d) (e) regulation 1994 european community (active implantable medical devices) regulation 1994 amended continue apply 27 may 2025 extent necessary application article 120(3) (4) eu regulation regulation revoked (5) purpose paragraph (1) (4) notwithstanding regulation 39 regulation 2 european community (medical devices) (amendment) regulation 2001 enforcement provision regulation 1994 european community (active implantable medical devices) regulation 1994 amended continue apply revoked period referred paragraph (6) notwithstanding provision regulation 6 month eudamed functionality date offence in-- (a) regulation 16(1)(z) (aa) (bb) (ll) (b) regulation 17(e) (f) (c) regulation 19(j) (k) (d) regulation 20(c) (d) (e) regulation 21(p) (f) regulation 25(o) apply far apply using eudamed mechanism information exchange (7) notwithstanding provision regulation 18 month eudamed functionality date offence in-- (a) regulation 16(1)(cc) (dd) (b) regulation 21(r) apply (8) notwithstanding provision regulations-- (a) 26 may 2023 class iia class iib device (b) 26 may 2025 class device offence regulation 16(1)(x) apply (9) notwithstanding provision regulation regard reusable device required bear udi carrier device itself-- (a) 26 may 2023 implantable device class iii device (b) 26 may 2025 class iia class iib device 261 45 (c) 26 may 2027 class device offence regulation 16(1)(x) apply (10) regulation-- directive 90 385 eec mean council directive 90 385 eec 20 june 19908 directive 93 42 eec mean council directive 93 42 eec 14 june 19939 eudamed functionality date mean date publication notice referred article 24(3) eu regulation 8 oj no l 189 20.7.1990 p 17 9 oj no l 169 12.7.1993 p 1 46 261 given official seal 25 may 2021 stephen donnelly minister health 261 47", "start_char": 95287, "end_char": 104058, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
{"doc_id": "si-2021-0261-explanatory-note", "parent_doc_id": "si-2021-0261", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 261 of 2021", "title": "Council of 5 April 20171, Regulation (EU) 2020/561 of the European Parliament", "year": 2021, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations— \n\n- \n\n- \n\n- \n\nconfer functions on the Health Products Regulatory Authority in relation \nto medical devices, \n\nlay down requirements for health institutions in relation to making \ninformation available to patients who have been implanted with \nimplantable devices, \n\nset out the national position with regard to reprocessing of single-use \ndevices to make them suitable for further use, \n\n- provide for various matters in relation to clinical investigations of \n\nmedical devices, and \n\n- provide offences for breaches of the requirements of Regulation (EU) \n2017/745 of the European Parliament and of the Council of 5 April 2017 \nand provisions herein. \n\n- \n\nThese Regulations may be cited as the Medical Devices Regulations 2021. \n\n \n \n \n \n \n \n \n \n \n \n \n \n\f48 [261] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \n52 FAICHE STIABHNA, BAILE ÁTHA CLIATH 2, \nD02 DR67. \n\nTeil: 076 110 6834 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \n52 ST. STEPHEN'S GREEN, DUBLIN 2, \nD02 DR67. \n\nTel: 076 110 6834 \nE-mail: publications@opw.ie \n—————— \n\n€8.00 \n\n(DH-254) 75. 5/21. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulations-- - - - confer function health product regulatory authority relation medical device lay requirement health institution relation making information available patient implanted implantable device set national position regard reprocessing single-use device make suitable use - provide various matter relation clinical investigation medical device - provide offence breach requirement regulation (eu) 2017 745 european parliament council 5 april 2017 provision herein - regulation may cited medical device regulation 2021 48 261 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais 52 faiche stiabhna baile atha cliath 2 d02 dr67 teil 076 110 6834 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication 52 st stephen green dublin 2 d02 dr67 tel 076 110 6834 e-mail publication opw.ie ------------ eur8.00 (dh-254) 75 5 21 propylon", "start_char": 104058, "end_char": 105409, "source_path": "downloads\\2021\\2021_0261.pdf", "extraction_method": "pdfminer", "checksum": "sha256:8d3bedea2af9ebfbb8bb01a519842f196541c56bb246b3b24175228113759bd2", "cross_refs": []}
